<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS156495</article-id><article-id pub-id-type="doi">10.1101/2022.10.27.514062</article-id><article-id pub-id-type="archive">PPR564520</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>HNRNPH1 regulates the neuroprotective cold-shock protein RBM3 expression through poison exon exclusion</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lin</surname><given-names>Julie Qiaojin</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Khuperkar</surname><given-names>Deepak</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pavlou</surname><given-names>Sofia</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Makarchuk</surname><given-names>Stanislaw</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Patikas</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Flora C.Y.</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Jianning</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Field</surname><given-names>Sarah F.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Zbiegly</surname><given-names>Julia M.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Freeman</surname><given-names>Joshua L.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Ule</surname><given-names>Jernej</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Metzakopian</surname><given-names>Emmanouil</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ruepp</surname><given-names>Marc-David</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Mallucci</surname><given-names>Giovanna R.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A6">6</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>UK Dementia Research Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 OAH, UK</aff><aff id="A2"><label>2</label>UK Dementia Research Institute, King’s College London, London, SE5 9NU, UK</aff><aff id="A3"><label>3</label>Open Targets, Wellcome Genome Campus, Cambridgeshire, CB10 1SA, UK</aff><aff id="A4"><label>4</label>The Francis Crick Institute, London, NW1 1AT, UK</aff><aff id="A5"><label>5</label>Tsinghua-Peking Joint Center for Life Sciences, School of Medicine and School of Life Sciences, Tsinghua University, Beijing 100084, China</aff><aff id="A6"><label>6</label>Altos Labs, Cambridge Institute of Science, Granta Park, Cambridge CB21 6GP, UK</aff><author-notes><corresp id="CR1">
<label>*</label>Correspondence: <email>ql256@cam.ac.uk</email> (J.Q.L.), <email>marc-david.ruepp@kcl.ac.uk</email> (M.-D.R.), <email>gmallucci@altoslabs.com</email> (G.R.M.)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>01</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>27</day><month>10</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><title>Summary</title><p id="P1">Enhanced expression of the cold-shock protein RNA binding motif 3 (RBM3) is highly neuroprotective both <italic>in vitro</italic> and <italic>in vivo</italic>. Whilst upstream signalling pathways leading to RBM3 expression have been described, the precise molecular mechanism of RBM3 induction during cooling remains elusive. To identify temperature-dependent modulators of RBM3, we performed a genome-wide CRISPR-Cas9 knockout screen using RBM3-reporter human iPSC-derived neurons. We found that RBM3 mRNA and protein levels are robustly regulated by several splicing factors, with heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) being the strongest positive regulator. Splicing analysis revealed that moderate hypothermia significantly represses the inclusion of a poison exon, which, when retained, targets the mRNA for nonsense-mediated decay. Importantly, we show that HNRNPH1 mediates this cold-dependent exon skipping via its interaction with a G-rich motif within the poison exon. Our study provides novel mechanistic insights into the regulation of RBM3 and provides further targets for neuroprotective therapeutic strategies.</p></abstract><abstract abstract-type="graphical"><p id="P2">
<fig id="F5" position="anchor"><label>Graphical Abstract</label><graphic xlink:href="EMS156495-f005"/></fig>
</p></abstract><kwd-group><kwd>Cold-shock protein</kwd><kwd>RBM3</kwd><kwd>neuroprotection</kwd><kwd>hypothermia</kwd><kwd>HNRNPH1</kwd><kwd>alternative splicing</kwd><kwd>poison exon</kwd><kwd>nonsense-mediated mRNA decay</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">Lowering brain temperature during therapeutic hypothermia to ~35°C is widely used for neuroprotection in clinical practice, including in birth asphyxia (<xref ref-type="bibr" rid="R11">Cornette, 2012</xref>), acute ischemic stroke (<xref ref-type="bibr" rid="R20">Hemmen and Lyden, 2009</xref>), traumatic brain injury (<xref ref-type="bibr" rid="R8">Chen et al., 2019</xref>) and cardiac arrest (<xref ref-type="bibr" rid="R45">Presciutti and Perman, 2022</xref>). While the mechanisms of hypothermia-induced neuroprotection in humans are not fully understood, the cold-shock protein RNA-binding motif 3 (RBM3) is used as a biomarker of good outcome of therapeutic hypothermia in the intensive care setting (<xref ref-type="bibr" rid="R2">Ávila-Gómez et al., 2020</xref>; <xref ref-type="bibr" rid="R50">Rosenthal et al., 2019</xref>). In preclinical studies, RBM3 is neuroprotective in multiple settings. <italic>In vivo,</italic> increased RBM3 protein levels (induced by cooling or overexpression) restore memory, prevent synapse and neuronal loss and extend survival of prion and Alzheimer’s diseases (<xref ref-type="bibr" rid="R4">Bastide et al., 2017</xref>; <xref ref-type="bibr" rid="R42">Peretti et al., 2015</xref>, <xref ref-type="bibr" rid="R43">2021</xref>); RBM3 stimulates neurogenesis in the rodent brain after hypoxic-ischemic brain injury and improves outcome (<xref ref-type="bibr" rid="R63">Zhu et al., 2019</xref>). <italic>In vitro,</italic> RBM3 protects neuronal cell lines from apoptosis during hypothermia (<xref ref-type="bibr" rid="R9">Chip et al., 2011</xref>). These findings have highlighted RBM3 as an attractive therapeutic target for neuroprotection - with the aim of inducing its expression without cooling. However, in this respect, a mechanistic understanding of its regulatory network is required.</p><p id="P4">In addition to hypothermia, RBM3 expression has been found to be modulated by hypoxia (<xref ref-type="bibr" rid="R58">Wellmann et al., 2004</xref>; <xref ref-type="bibr" rid="R60">Yan et al., 2019</xref>), serum starvation (<xref ref-type="bibr" rid="R59">Wellmann et al., 2010</xref>), metformin (<xref ref-type="bibr" rid="R32">Laustriat et al., 2015</xref>) and morphine exposure (<xref ref-type="bibr" rid="R29">Koo et al., 2012</xref>; <xref ref-type="bibr" rid="R33">Lefevre et al., 2020</xref>). Hypothermia induces RBM3 protein expression in association with TrkB activation <italic>in vivo</italic> (<xref ref-type="bibr" rid="R43">Peretti et al., 2021</xref>), but the exact molecular mechanism controlling RBM3 expression downstream of these signalling cascades and other modulators, remains unclear. Interestingly, hypothermia, metformin and hypoxia all alter genome-wide alternative splicing (<xref ref-type="bibr" rid="R32">Laustriat et al., 2015</xref>; <xref ref-type="bibr" rid="R39">Natua et al., 2021</xref>; <xref ref-type="bibr" rid="R40">Neumann et al., 2020</xref>) and differential splicing leading to altered mRNA and protein expression which is common among many RNA-binding proteins (<xref ref-type="bibr" rid="R31">Lareau et al., 2007</xref>; <xref ref-type="bibr" rid="R38">Müller-McNicoll et al., 2019</xref>; <xref ref-type="bibr" rid="R54">Sun et al., 2017</xref>). In particular, hypothermia-induced alternative splicing is observed in cold-inducible RNA-binding protein (CIRBP) transcripts (<xref ref-type="bibr" rid="R16">Gotic et al., 2016</xref>). These findings raise an interesting possibility that RBM3 gene expression could be fine-tuned on cooling in part by alternative splicing of its mRNA transcripts.</p><p id="P5">In this study, we uncovered the molecular mechanism involved in the cold induction of RBM3. An unbiased CRISPR/Cas9 whole-genome knockout screen in human induced pluripotent stem cell (iPSC)-derived neurons (i-neurons) identified several splicing factors, including heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1), as transacting regulators of neuronal RBM3. We showed that HNRNPH1 mediates temperature-dependent RBM3 mRNA alternative splicing in multiple cell types, and maintains RBM3 transcript and protein expression in cooperation with the nonsense-mediated mRNA decay (NMD) pathway. Additionally, we located temperature-dependent cis-regulatory elements in the RBM3 mRNA and demonstrated that its functional interaction with HNRNPH1 is a key determinant of RBM3 differential splicing. These findings increase the range of therapeutic targets for RBM3 induction.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Pooled CRISPR knockout screen identifies RNA splicing as a key regulatory pathway for RBM3</title><p id="P6">An RBM3 reporter iPSC line was generated by Cas9-mediated homology-directed repair to insert GFP at the N-terminus of the single copy of RBM3 on chromosome X in wild-type (WT) iPSCs, which contain a doxycycline (Dox)-inducible neurogenin 2 expression cassette (<xref ref-type="bibr" rid="R41">Pawlowski et al., 2017</xref>) and express Cas9 driven by the GAPDH promoter (Cas9 WT) (<xref ref-type="supplementary-material" rid="SD1">Fig. S1A</xref>). GFP-RBM3 predominantly localised to the nucleus in iPSCs (<xref ref-type="supplementary-material" rid="SD1">Fig. S1B</xref>) and i-neurons (<xref ref-type="fig" rid="F1">Fig. 1A</xref>), consistent with previous reports (<xref ref-type="bibr" rid="R51">Rzechorzek et al., 2015</xref>). In this study, all Cas9-mediated gene editing in i-neurons was conducted by lentiviral transduction 4 days post differentiation, when Cas9 expression is optimal (<xref ref-type="supplementary-material" rid="SD1">Fig. S1A</xref>). Editing efficiencies were measured to be above 60% in GFP-RBM3 i-neurons 18 days post differentiation (<xref ref-type="supplementary-material" rid="SD1">Fig. S1C</xref>).</p><p id="P7">GFP fluorescence intensities in both clones of GFP-RBM3 i-neurons were significantly enhanced by cooling at 32°C for 72h (<xref ref-type="fig" rid="F1">Fig. 1A</xref>, <xref ref-type="supplementary-material" rid="SD1">S1D</xref>) as a result of increased nuclear and cytosolic GFP-RBM3 levels (<xref ref-type="supplementary-material" rid="SD1">Fig. S1E</xref>). Around 30% cold-induction of GFP-RBM3 protein levels was also shown by western blots (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). These observations validated that endogenously GFP-tagged RBM3 is temperature-sensitive, consistent with behaviours of unmodified RBM3 both seen with the Cas9 WT cells in this study and reported RBM3 hypothermic induction (<xref ref-type="bibr" rid="R25">Jackson et al., 2015</xref>; <xref ref-type="bibr" rid="R42">Peretti et al., 2015</xref>).</p><p id="P8">Using both clones of this characterised GFP-RBM3 reporter line, we performed an RBM3 CRISPR knockout pooled screen (<xref ref-type="fig" rid="F1">Fig. 1C</xref>) by transducing 4-day differentiated cells with a custom-made whole-genome sgRNA lentiviral library, targeting critical exons of 18466 genes across the human genome, co-expressing a BFP reporter. Day 18 i-neurons were incubated at 32°C for 72h before dissociation and fluorescence-activated cell sorting (FACS). BFP-positive cells with the highest and lowest GFP-RBM3 expression, which fell in the top and bottom quartile of GFP intensity profiles, were separately collected, denoted as high GFP and low GFP populations. Genomic DNA was sequenced to identify sgRNAs enriched in high or low GFP populations (see Table S2). Ranked by the false discovery rate (FDR), 15 genes, including RBM3, were enriched in low GFP i-neurons, suggesting they likely positively regulate RBM3 expression (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). In contrast, 95 genes, likely to negatively affect RBM3 expression, were enriched in high GFP populations (<xref ref-type="fig" rid="F1">Fig. 1E</xref>).</p><p id="P9">Gene ontology and network analysis revealed that a major group of RBM3 regulator candidates are involved in RNA splicing (<xref ref-type="fig" rid="F1">Fig. 1F, G</xref>), including spliceosomal proteins, e.g., U1 small nuclear ribonucleoprotein 70 kDa (SNRNP70), heterogeneous nuclear ribonucleoproteins (hnRNPs) and serine and arginine rich splicing factors (SRSFs). Other potential RBM3 regulators play roles in nucleocytoplasmic transport, e.g. transportin 3 (TNPO3) and karyopherin-β1 (KPBN1); translation, e.g. 60S acidic ribosomal protein P2 (RPLP2) and eukaryotic translation initiation factor 3 subunit B (EIF3B); transcription, e.g. transcription initiation factor TFIID subunit 4 (TAF4); ubiquitination, e.g. ubiquitin-conjugating enzyme E2 H (UBE2H).</p></sec><sec id="S4"><title>Arrayed target validation reveals regulators modulating neuronal RBM3 protein and transcript abundance</title><p id="P10">To validate the top hits identified by the pooled screen, we individually depleted the top 30 RBM3 positive and negative regulator candidates using 1-3 sgRNAs per gene from the whole-genome library (see Table S3). I-neurons transduced with 3 non-targeting sgRNAs from the pooled library or the reporter lentivirus for editing efficiency calculation served as controls. As a positive control, RBM3 sgRNAs reduced GFP fluorescence by over 80% compared to non-targeting sgRNAs at 37°C or 32°C (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). Moderate spectral crossover and activation of specific signalling pathways due to target-specific genome editing may account for the discrepancy between non-targeting sgRNA and reporter controls. To apply a more stringent standard, we performed statistical analysis between specific gene knockout (KO) groups and one of the two control groups with high p values, for instance, comparing to the non-targeting sgRNA control showing lower GFP intensity to identify positive regulators, and to the reporter control for negative regulators. Knocking out 7 out of 29 positive regulator candidates tested significantly reduced GFP-RBM3 levels at 37°C and 32°C (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). HNRNPH1 (<xref ref-type="bibr" rid="R10">Chou et al., 1999</xref>), TNPO3 (<xref ref-type="bibr" rid="R26">Kataoka et al., 1999</xref>), PNN Interacting Serine And Arginine Rich Protein (PNISR) (<xref ref-type="bibr" rid="R64">Zimowska et al., 2003</xref>) and SNRNP70 (<xref ref-type="bibr" rid="R44">Pomeranz Krummel et al., 2009</xref>) are associated with RNA splicing. Among 30 tested RBM3 negative regulator candidates, KO of 6 genes significantly increased GFP-RBM3 expression in i-neurons at 37°C and 32°C (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Specifically, HIV-1 Tat Specific Factor 1 (HTATSF1) and WT1 Associated Protein (WTAP) are splicing regulators, while Yippee Like 5 (YEPL5), WD Repeat Domain 26 (WDR26) and UBE2H mediate ubiquitination and proteasomal degradation, the depletion of which is more likely to result in generic instead of RBM3-specific protein accumulation. Changes in GFP-RBM3 levels upon selective RBM3 regulator KO were also confirmed using fluorescent microscopy (<xref ref-type="supplementary-material" rid="SD1">Fig. S2A</xref>). Collectively, the arrayed CRISPR knockout assay validated hits associated with the lowest FDR in the pooled screen (<xref ref-type="fig" rid="F1">Fig. 1D, E</xref>), and reiterated that multiple components of the splicing machinery are key to RBM3 protein expression.</p><p id="P11">To investigate whether the cold-induced GFP-RBM3 protein expression is controlled at the translational or transcriptional level, the translational inhibitor cycloheximide or the RNA polymerase inhibitor actinomycin D was applied to i-neurons at 37°C or 32°C. The elevation of GFP-RBM3 in cooled cells was completely abolished by either inhibitor (<xref ref-type="supplementary-material" rid="SD1">Fig. S2B</xref>), indicating the cold-increased GFP-RBM3 expression relies on the <italic>de novo</italic> transcription and translation of RBM3 transcripts. In line with this finding, differential expression analysis comparing RNA-Seq data between i-neurons at 37°C and 32°C showed RBM3 increased 4-fold on cooling: this was the most significant increase across the entire transcriptome (<xref ref-type="supplementary-material" rid="SD1">Fig. S2C</xref>). Further, real-time PCR (quantitative PCR, qPCR) of RBM3 mRNA supports cold-induction of RBM3 mRNA by 3-5 folds in Cas9 WT i-neurons (<xref ref-type="fig" rid="F2">Fig. 2C</xref>, <xref ref-type="supplementary-material" rid="SD1">S2D</xref>) and HeLa cells (<xref ref-type="supplementary-material" rid="SD1">Fig. S2E</xref>).</p><p id="P12">We next explored whether the changes of RBM3 protein expression upon individual regulator KO were due to altered RBM3 mRNA levels. We focused on the validated splicing regulating genes (HNRNPH1, PNISR, SNRNP70, HTATSF1, WTAP), potential regulators marginally affecting RBM3 expression (Poly(U) Binding Splicing Factor 60 (PUF60) and LUC7 Like 3 Pre-mRNA Splicing Factor (LUC7L3)) and the two nuclear protein importers (TNPO3 and KPNB1) (<xref ref-type="fig" rid="F2">Fig. 2D, E</xref>). Due to cell death and promoter silencing, only 15-45% of the transduced cells remained BFP-positive, as approximates to transduction efficiencies (labelled on bars, <xref ref-type="fig" rid="F2">Fig. 2D, E</xref>), on day 18 when RNA was extracted from i-neuron cultures at 37°C or 32°C. Remarkably, the extent of RBM3 transcript reduction due to HNRNPH1 KO at 37°C or 32°C was similar to RBM3 KO as a positive control (<xref ref-type="fig" rid="F2">Fig. 2D, E</xref>), revealing HNRNPH1 as a strong positive regulator of RBM3 mRNA expression. TNPO3, PNISR, SNRNP70 and PUF60 KO also significantly lowered RBM3 transcript levels at 32°C (<xref ref-type="fig" rid="F2">Fig. 2E</xref>), suggesting they are key regulators for cold induction of RBM3 transcripts. On the contrary, none of the tested negative regulator KO affected RBM3 mRNA expression, suggesting that their regulation may be at the translational or post-translational level. In support of our findings in i-neurons, RNA-Seq analysis of public data also showed reduced RBM3 mRNA levels upon HNRNPH1, SNRNP70 and PUF60 KD in K562 or HepG2 cells, while no difference was seen upon KPNB1 KD (<xref ref-type="supplementary-material" rid="SD1">Fig. S2F</xref>) (<xref ref-type="bibr" rid="R13">ENCODE Project Consortium, 2012</xref>; <xref ref-type="bibr" rid="R35">Luo et al., 2020</xref>). Particularly, both the mRNA and protein levels of RBM3 were most significantly reduced across the whole genome upon HNRNPH1 KD in HeLa cells (<xref ref-type="bibr" rid="R56">Uren et al., 2016</xref>), demonstrating the strong regulatory effect of HNRNPH1 on RBM3 transcripts and proteins. We further showed that HNRNPH1 KD significantly decreased RBM3 mRNA in HeLa cells by over 50% both at 37°C and 32°C (<xref ref-type="supplementary-material" rid="SD1">Fig. S2G</xref>). To summarise, depleting specific splicing factors, particularly HNRNPH1, abolishes the cold-induced increase of RBM3 mRNA expression in i-neurons and other cell types.</p></sec><sec id="S5"><title>RBM3 poison exon that triggers nonsense-mediated decay is silenced during hypothermia</title><p id="P13">Given that RBM3 mRNA expression is tightly regulated by splicing factors in i-neurons, we searched for RBM3 alternatively spliced isoforms with RNA-Seq data acquired from Cas9 WT i-neurons at 37°C and 32°C (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). Multiple isoforms of RBM3 transcripts were identified and the most abundant four isoforms could be distinguished by either Exon 3, Exon 3a-L or Exon 3a-S inclusion (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). Differential splicing analysis showed RBM3 Exon 3a inclusion levels drastically reduced upon cooling, from the percent spliced in (PSI) index of 0.023 to 0.002 for Exon 3a-L, or from 0.015 to 0.001 for Exon 3a-S (<xref ref-type="fig" rid="F3">Fig. 3B</xref>, Table S4), while Exon 3 inclusion levels remained similar at 37°C and 32°C (<xref ref-type="supplementary-material" rid="SD1">Fig. S3A</xref>), demonstrating that cooling effectively repressed the production of Exon 3a-L/S-containing RBM3 transcripts.</p><p id="P14">A close examination of Exon 3a of RBM3 revealed multiple stop codons in-frame with the coding sequence, potentially leading to premature translational termination (<xref ref-type="bibr" rid="R34">Llorian et al., 2016</xref>). Thus, the inclusion of Exon 3a makes the RBM3 transcript a susceptible target for degradation by nonsense-mediated mRNA decay (NMD), an mRNA surveillance pathway that degrades mRNAs that harbour premature termination codons (PTCs) (<xref ref-type="bibr" rid="R19">He and Jacobson, 2015</xref>). Exon 3a could therefore serve as a poison exon (PE) in RBM3 mRNA, leading to a reduction of the transcript level if retained. Such post-transcriptional regulation mediated by PEs is key to fine-tuning expression levels for many proteins, especially RNA-binding proteins (<xref ref-type="bibr" rid="R40">Neumann et al., 2020</xref>). To further verify if Exon 3a indeed acts as a PE, and to explore the temperature-dependent inclusion of RBM3 PE quantitatively, we designed isoform-sensitive primers to amplify regions between RBM3 exon 3 and exon 4 to identify PE-included or PE-skipped isoforms of RBM3 transcripts (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). In order to detect the NMD-sensitive PE-included isoforms, we blocked NMD using a chemical inhibitor of SMG1 kinase, a key member of the NMD pathway (<xref ref-type="bibr" rid="R30">Langer et al., 2021</xref>). When i-neurons were incubated with SMG1 inhibitor for 24h at 37°C, both PE-included and PE-skipped isoforms were detected with RT-PCR. Interestingly, in 72h-cooled i-neurons, only the PE-skipped isoform was detected, even after SMG1 inhibitor treatment, clearly supporting that the RBM3 PE was preferentially excluded in cooled i-neurons (<xref ref-type="fig" rid="F3">Fig. 3D</xref>). This finding was further validated by qPCR using primers against Exon 3a (detecting both 3a-L and 3a-S) and the constitutive exons, e.g., Exon 3 and Exon 4-5 (<xref ref-type="fig" rid="F3">Fig. 3E</xref>). The fraction of PE-contained transcripts to the total transcripts at 37°C was over 5 times more compared to the fraction at 32°C. When NMD was inhibited by the SMG1 inhibitor, the differences rose to 13-15 folds (<xref ref-type="fig" rid="F3">Fig. 3E</xref>).</p><p id="P15">Additionally, we designed an RBM3 minigene spanning RBM3 Exons 1-4, which was sensitive to NMD when expressed in HeLa cells (<xref ref-type="fig" rid="F3">Fig. 3F</xref>). Consistent with the endogenous RBM3 mRNA (<xref ref-type="fig" rid="F3">Fig. 3F</xref>), the minigene also showed a significantly lower fraction of PE-retained isoform at 32°C compared to 37°C, when NMD was blocked by SMG1 inhibitor (<xref ref-type="fig" rid="F3">Fig. 3G</xref>) or cycloheximide (<xref ref-type="supplementary-material" rid="SD1">Fig. S3B</xref>).</p></sec><sec id="S6"><title>HNRNPH1 represses RBM3 poison exon inclusion at low temperatures</title><p id="P16">We next investigated whether positive RBM3 mRNA regulators control RBM3 transcript abundance through PE skipping. When NMD was inhibited, knocking down HNRNPH1 resulted in RBM3 PE retention in i-neurons, with 29% increase at 37°C and 57% increase at 32°C compared to the respective non-targeting control (<xref ref-type="fig" rid="F4">Fig. 4A, B</xref>). RBM3 PE-retention upon HNRNPH1 KD was also found in published RNA-Seq analysis using K562 and HepG2 cells, demonstrating its conserved role across multiple cell types (<xref ref-type="fig" rid="F4">Fig. 4C</xref>, <xref ref-type="supplementary-material" rid="SD1">S4A, S4B</xref>, Table S4) (<xref ref-type="bibr" rid="R13">ENCODE Project Consortium, 2012</xref>; <xref ref-type="bibr" rid="R35">Luo et al., 2020</xref>). In HeLa cells treated with SMG1 inhibitor, RNAi-mediated HNRNPH1 knockdown (<xref ref-type="supplementary-material" rid="SD1">Fig. S4C</xref>) increased PE retention in endogenous RBM3 transcripts (<xref ref-type="fig" rid="F4">Fig. 4D</xref>) and in RBM3 minigene (<xref ref-type="fig" rid="F4">Fig. 4E</xref>) only at 32°C when NMD was inhibited, suggesting that the role of HNRNPH1 in repressing RBM3 PE inclusion is context-dependent, being more important under the cooled condition. Moreover, overexpressing FLAG-tagged HNRNPH1 in HEK293T cells (<xref ref-type="supplementary-material" rid="SD1">Fig. S4D</xref>) repressed PE inclusion in endogenous RBM3 mRNA (<xref ref-type="fig" rid="F4">Fig. 4F</xref>) and in the minigene (<xref ref-type="fig" rid="F4">Fig. 4G</xref>) at 37°C, confirming the splicing-regulatory function of HNRNPH1 in RBM3 PE exclusion.</p><p id="P17">Given the strong correlation between HNRNPH1 and RBM3 expression, we speculated that HNRNPH1 expression is temperature dependent. To our surprise, HNRNPH1 protein levels or its interaction with spliceosomes, shown by core spliceosomal protein SmB pulldown, were not altered by cooling (<xref ref-type="supplementary-material" rid="SD1">Fig. S4E, S4F</xref>), suggesting that cooling-related regulation of RBM3 mRNA by HNRNPH1 is not driven by generic changes in HNRNPH1 spliceosomal association. We next explored whether the physical interaction between HNRNPH1 and RBM3 pre-mRNA is more important at 32°C by evaluating the efficiency of RBM3 PE removal when the HNRNPH1 binding site in the RBM3 intron is abolished. The intronic sequence between RBM3 Exon 3 and 4 contains multiple poly-G stretches (<xref ref-type="fig" rid="F4">Fig. 4H</xref>), which are known as HNRNPH1 consensus binding sites (<xref ref-type="bibr" rid="R7">Caputi and Zahler, 2001</xref>; <xref ref-type="bibr" rid="R56">Uren et al., 2016</xref>). Indeed, analysis of published HNRNPH1 Individual-nucleotide resolution UV crosslinking and immunoprecipitation (iCLIP) dataset in HEK293T cells (<xref ref-type="bibr" rid="R5">Braun et al., 2018</xref>) revealed that HNRNPH1 strongly interacts with GGGG motifs at the 5’ end of PE (near 3’ splice site) and 30 nucleotides upstream of the 5’ splice site between RBM3 Exon 3 and 4 (<xref ref-type="fig" rid="F4">Fig. 4H</xref>). Strikingly, the removal of this single GGGG motif was sufficient to dramatically increase PE inclusion and almost completely incapacitate its skipping upon cooling, but not at 37°C (<xref ref-type="fig" rid="F4">Fig. 4I</xref>), recapitulating PE inclusion due to HNRNPH1 KD at 32°C (<xref ref-type="fig" rid="F4">Fig. 4E</xref>). Taken together, the results show that HNRNPH1 interacts with the G-rich motif within the PE to repress RBM3 PE inclusion most efficiently upon cooling.</p><p id="P18">It is worth noting that G-rich sequences have a tendency to form RNA G-quadruplex (rG4) secondary structures (<xref ref-type="bibr" rid="R27">Kharel et al., 2020</xref>), which are highly enriched at weak splice sites and promote cassette exon inclusion (<xref ref-type="bibr" rid="R14">Georgakopoulos-Soares et al., 2022</xref>; <xref ref-type="bibr" rid="R23">Huang et al., 2017</xref>). Intriguingly, HNRNPH1 has been recently reported as an interactor and destabilizer of rG4s (<xref ref-type="bibr" rid="R57">Vo et al., 2022</xref>). Therefore, destabilising rG4s by HNRNPH1 is likely to induce exon skipping, as reported for HNRNPH1-mediated exon exclusion in RNA-binding protein EWS (EWSR1) transcripts (<xref ref-type="bibr" rid="R57">Vo et al., 2022</xref>). Consistent with this hypothesis, sequence-based rG4 prediction suggests the presence of rG4s in the region between RBM3 Exon 3 and 4 that overlaps with the primary HNRNPH1 binding site (<xref ref-type="fig" rid="F4">Fig. 4H</xref>). Deletion of the GGGG motif in the mutant minigene is predicted to disrupt the rG4 (<xref ref-type="supplementary-material" rid="SD1">Fig. S4G</xref>), suggesting a potential connection between altered rG4 stability and temperature-sensitive alternative splicing of RBM3 mRNA.</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P19">Using a genome-wide CRISPR/Cas9 gene KO screen, we identified key trans-regulatory factors for neuronal RBM3 cold-induction. The strength of our screen lies in its closely recapitulating the physiological scenario, because we chose to a) GFP-tag endogenous RBM3 loci to account for any regulatory element beyond the coding sequence, b) use fully differentiated i-neurons with functional synapses, and c) pre-cool at 32°C to extend the dynamic range of GFP-RBM3 fluorescent readings affected by positive and negative regulator depletion. While splicing regulating proteins were identified among the strongest RBM3 regulators, our screen also indicated that RBM3 protein expression is controlled at multiple levels, from transcription, translation to protein degradation. It will be interesting to explore the overlap between cooling-dependent modulators of RBM3 identified in this study and regulators involved in changes of RBM3 levels by other known stimuli, such as BDNF/TrkB signalling cascade we previously reported (<xref ref-type="bibr" rid="R43">Peretti et al., 2021</xref>).</p><p id="P20">The appearance of HNRNPH1 as the top positive regulator of RBM3 together with other splicing factors prompted us to investigate cold-induced splicing changes in RBM3 mRNA. In line with this, we report cooling-dependent PE exclusion as a level of regulation governing RBM3 induction. Interestingly, this alternative splicing regulation is conserved in different cell types and between human and mouse (<xref ref-type="bibr" rid="R46">Preussner et al., 2022</xref>). Depletion of HNRNPH1 using different methods disrupted the alternative splicing control around RBM3 PE in endogenous RBM3 mRNA and in an externally introduced minigene. Moreover, removal of the poly-G stretches within the PE significantly repressed the removal of PE in RBM3 transcript, further conclusively establishing the role of HNRNPH1 binding.</p><p id="P21">It is interesting that depletion of HNRNPH1 leads to enhanced RBM3 PE retention at 32°C but exerted little impact at 37°C (<xref ref-type="fig" rid="F4">Fig. 4D</xref>), supporting a cold-dependent efficacy of HNRNPH1 in RBM3 PE repression. The low efficiency of HNRNPH1 in RBM3 PE removal at 37°C is compensated by its overexpression (<xref ref-type="fig" rid="F4">Fig. 4F</xref> and <xref ref-type="fig" rid="F4">4G</xref>), but this does not explain its cold-dependency, since HNRNPH1 expression is not changed upon cooling (<xref ref-type="supplementary-material" rid="SD1">Fig. S4E</xref>). Thus, the increased repressive capacity of HNRNPH1 may be explained by either or both of the following mechanisms. First, colder temperatures are known to enhance rG4s structural stability both directly (<xref ref-type="bibr" rid="R37">Moon et al., 2015</xref>; <xref ref-type="bibr" rid="R61">Yang et al., 2022</xref>) and indirectly due to modified enzymatic activities of RNA helicases and other RNA chaperones. Formation of rG4 could increase the capacity of HNRNPH1 to compete with other RBPs on the corresponding intronic region and thereby effectively repress the RBM3 PE. Alternatively, post-translational modification (PTM) and/or temperature-driven condensation of HNRNPH1 (<xref ref-type="bibr" rid="R28">Kim and Kwon, 2021</xref>) might modify its affinity for targeted RNA regions. Temperature variation can result in markedly different PTM patterns shaped by temperature-sensitive PTM enzymes (<xref ref-type="bibr" rid="R6">Cai et al., 2018</xref>), including kinases (<xref ref-type="bibr" rid="R17">Haltenhof et al., 2020</xref>) and arginine methyltransferases (<xref ref-type="bibr" rid="R22">Hong et al., 2010</xref>). In fact, in <italic>vitro</italic> and <italic>in vivo</italic> evidence supports temperature-dependent changes in RNA-RBP condensation (<xref ref-type="bibr" rid="R24">Iserman et al., 2020</xref>; <xref ref-type="bibr" rid="R36">Molliex et al., 2015</xref>; <xref ref-type="bibr" rid="R47">Pullara et al., 2022</xref>; <xref ref-type="bibr" rid="R49">Riback et al., 2017</xref>) as a result of differential intermolecular interactions (<xref ref-type="bibr" rid="R55">Tauber et al., 2020</xref>), possibly linked to distinct PTM of the embedded RBPs (<xref ref-type="bibr" rid="R21">Hofweber and Dormann, 2019</xref>; <xref ref-type="bibr" rid="R53">Sridharan et al., 2022</xref>).</p><p id="P22">Interestingly, HNRNPH1 missense mutations in the nuclear localisation sequence and nonsense mutations leading to reduced protein levels have been identified in individuals with neurodevelopmental disorders and intellectual impairment (<xref ref-type="bibr" rid="R15">Gillentine et al., 2021</xref>; <xref ref-type="bibr" rid="R48">Reichert et al., 2020</xref>). A possibility is that these mutations may act, in part, through impaired HNRNPH1 induction of RBM3 expression, affecting its roles in neurogenesis (<xref ref-type="bibr" rid="R63">Zhu et al., 2019</xref>) and/or synaptic maintenance (<xref ref-type="bibr" rid="R42">Peretti et al., 2015</xref>, <xref ref-type="bibr" rid="R43">2021</xref>). In addition, HNRNPH1 sequestration in RNA foci has been implicated in neurodegenerative disease models of frontotemporal dementia, associated with impaired splicing functions (<xref ref-type="bibr" rid="R3">Bampton et al., 2020</xref>). It would be exciting to explore the effect of these HNRNPH1 mutations, and its sequestration in RNA foci, on RBM3 splicing and hence RBM3 protein levels.</p><p id="P23">The fate of inclusion or exclusion of alternative exons is a consequence of the interplay between the recruited splicing factors and the cis-acting elements with varying affinities, opening up opportunities for targeting different steps during mRNA splicing as therapeutic interventions (<xref ref-type="bibr" rid="R12">El Marabti and Abdel-Wahab, 2021</xref>). Although small molecules affecting global splicing activity has been applied to cancer treatments (<xref ref-type="bibr" rid="R1">Agrawal et al., 2018</xref>), modulating specific splicing events by targeting cis-acting elements using splice-switching antisense oligonucleotides (ASOs) has confirmed its therapeutic benefits in several genetic diseases, including spinal muscular atrophy and Duchenne muscular dystrophy (<xref ref-type="bibr" rid="R18">Havens and Hastings, 2016</xref>). Repressing PE inclusion in RBM3 using ASOs successfully upregulates RBM3 expression for neuroprotection in mice with prion neurodegeneration (<xref ref-type="bibr" rid="R46">Preussner et al., 2022</xref>). The past two decades have witnessed the development of splicing control using bifunctional oligonucleotides, consisting of an antisense domain complementary to the mRNA region close to the splice site, and a tail domain recruiting RBPs to promote exon inclusion or exclusion (<xref ref-type="bibr" rid="R52">Skordis et al., 2003</xref>; <xref ref-type="bibr" rid="R62">Zhou, 2022</xref>). Identifying HNRNPH1 as an RBM3 PE repressor brings the potential to apply this technology, providing novel targets to maintain RBM3 levels in both acute brain injury and in neurodegenerative disorder patients, with potential new therapeutic avenues for dementia treatments.</p></sec><sec id="S8"><title>Key resources table</title><table-wrap id="T1" orientation="portrait" position="anchor"><table frame="box" rules="all"><tbody><tr><td valign="middle" align="left">REAGENT or RESOURCE</td><td valign="middle" align="left">SOURCE</td><td valign="middle" align="left">IDENTIFIER</td></tr><tr><td valign="middle" align="left" colspan="3">Antibodies</td></tr><tr><td valign="middle" align="left">Rabbit anti-RBM3 antibody</td><td valign="middle" align="left">Proteintech</td><td valign="middle" align="left">Cat#14363-1-AP</td></tr><tr><td valign="middle" align="left">Rabbit anti-GFP antibody</td><td valign="middle" align="left">Abcam</td><td valign="middle" align="left">Cat#ab290</td></tr><tr><td valign="middle" align="left">Mouse anti-Cas9 antibody</td><td valign="middle" align="left">Cell Signaling</td><td valign="middle" align="left">Cat#14597S</td></tr><tr><td valign="middle" align="left">Mouse anti-GAPDH antibody</td><td valign="middle" align="left">Santa Cruz</td><td valign="middle" align="left">Cat#sc-32233</td></tr><tr><td valign="middle" align="left">Rabbit anti-HNRNPH1 antibody</td><td valign="middle" align="left">Bethyl</td><td valign="middle" align="left">Cat#A300-511A</td></tr><tr><td valign="middle" align="left">Mouse anti-FLAG</td><td valign="middle" align="left">Sigma</td><td valign="middle" align="left">Cat#F1804</td></tr><tr><td valign="middle" align="left">Rabbit anti-SmD3 antibody</td><td valign="middle" align="left">Antibodies Online</td><td valign="middle" align="left">Cat#ABIN653228</td></tr><tr><td valign="middle" align="left">Mouse anti-SM proteins antibody</td><td valign="middle" align="left">(Lerner et al., 1981)</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Goat anti-rabbit HRP secondary antibody</td><td valign="middle" align="left">Biorad</td><td valign="middle" align="left">Cat#1706515</td></tr><tr><td valign="middle" align="left">Goat anti-mouse HRP secondary antibody</td><td valign="middle" align="left">Biorad</td><td valign="middle" align="left">Cat#1706516</td></tr><tr><td valign="middle" align="left">Donkey anti-rabbit 680LT</td><td valign="middle" align="left">LI-COR</td><td valign="middle" align="left">Cat#926-68023</td></tr><tr><td valign="middle" align="left">Donkey anti-mouse 680LT</td><td valign="middle" align="left">LI-COR</td><td valign="middle" align="left">Cat#926-68022</td></tr><tr><td valign="middle" align="left">Donkey anti-rabbit 800CW</td><td valign="middle" align="left">LI-COR</td><td valign="middle" align="left">Cat#926-32213</td></tr><tr><td valign="middle" align="left">Donkey anti-mouse 800CW</td><td valign="middle" align="left">LI-COR</td><td valign="middle" align="left">Cat#926-32212</td></tr><tr><td valign="middle" align="left" colspan="3">Bacterial and virus strains</td></tr><tr><td valign="middle" align="left">5-alpha Competent E. coli</td><td valign="middle" align="left">NEB</td><td valign="middle" align="left">Cat#C2987</td></tr><tr><td valign="middle" align="left">One Shot ccdB Survival 2 T1R Competent Cells</td><td valign="middle" align="left">ThermoFisher Scientific</td><td valign="middle" align="left">Cat#A10460</td></tr><tr><td valign="middle" align="left">Stable Competent E. coli (High Efficiency)</td><td valign="middle" align="left">NEB</td><td valign="middle" align="left">Cat#C3040I</td></tr><tr><td valign="middle" align="left">Lentivirus: pLVPB-gCherry-PGK-BFP-2A-mCherry</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Lentivirus: whole-genome CRISPR sgRNA library</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Lentivirus: sgRNA-expressing lentivirus (each contains one of the sgRNAs listed in Table S1)</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left" colspan="3">Chemicals, peptides, and recombinant proteins</td></tr><tr><td valign="middle" align="left">TeSR-E8 Medium</td><td valign="middle" align="left">Stemcell Technologies</td><td valign="middle" align="left">Cat#05990</td></tr><tr><td valign="middle" align="left">StemFlex Medium</td><td valign="middle" align="left">ThermoFisher Scientific</td><td valign="middle" align="left">Cat#A3349401</td></tr><tr><td valign="middle" align="left">EDTA, pH8.0</td><td valign="middle" align="left">ThermoFisher Scientific</td><td valign="middle" align="left">Cat#15575020</td></tr><tr><td valign="middle" align="left">Vitronectin</td><td valign="middle" align="left">ThermoFisher Scientific</td><td valign="middle" align="left">Cat#A14700</td></tr><tr><td valign="middle" align="left">Cryostor Cs10 Cryopreservation</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#C2874-100ML</td></tr><tr><td valign="middle" align="left">StemPro Accutase Cell Dissociation Reagent</td><td valign="middle" align="left">ThermoFisher Scientific</td><td valign="middle" align="left">Cat#A1110501</td></tr><tr><td valign="middle" align="left">0.25% Trypsin-EDTA</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#T4049</td></tr><tr><td valign="middle" align="left">Rho-associated protein kinase (ROCK) inhibitor</td><td valign="middle" align="left">BD Biosciences</td><td valign="middle" align="left">Cat#Y-27632</td></tr><tr><td valign="middle" align="left">Geltrex LDEV-Free, hESC-Qualified, Reduced Growth</td><td valign="middle" align="left">Life Technologies</td><td valign="middle" align="left">Cat#A1413302</td></tr><tr><td valign="middle" align="left">DMEM/F12, GlutaMAX Supplement</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#31331028</td></tr><tr><td valign="middle" align="left">N-2 Supplement (100X)</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#17502048</td></tr><tr><td valign="middle" align="left">MEM Non-Essential Amino Acids Solution (100X)</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat# 11140050</td></tr><tr><td valign="middle" align="left">2-Mercaptoethanol (50 mM)</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#31350010</td></tr><tr><td valign="middle" align="left">Doxycycline hyclate</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#D9891</td></tr><tr><td valign="middle" align="left">Neurobasal medium</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#21103049</td></tr><tr><td valign="middle" align="left">Neurobasal medium, minus phenol red</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#12348017</td></tr><tr><td valign="middle" align="left">B-27 Supplement (50X), minus vitamin A</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#12587010</td></tr><tr><td valign="middle" align="left">GlutaMAX Supplement</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat# 35050061</td></tr><tr><td valign="middle" align="left">Neurotrophin-3 (NT-3)</td><td valign="middle" align="left">PeproTech</td><td valign="middle" align="left">Cat#450-03</td></tr><tr><td valign="middle" align="left">Brain Derived Neurotrophic Factor (BDNF)</td><td valign="middle" align="left">PeproTech</td><td valign="middle" align="left">Cat#450-02</td></tr><tr><td valign="middle" align="left">Penicillin-Streptomycin</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#15140122</td></tr><tr><td valign="middle" align="left">HiFi Cas9 nuclease V3</td><td valign="middle" align="left">Integrated DNA Technologies</td><td valign="middle" align="left">Cat#1081060</td></tr><tr><td valign="middle" align="left">Proteinase K, recombinant, PCR grade</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#EO0491</td></tr><tr><td valign="middle" align="left">Sodium Acetate, 3M, pH 5.2</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#567422-100ML</td></tr><tr><td valign="middle" align="left">Poly-L-lysine</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#P4707</td></tr><tr><td valign="middle" align="left">Laminin</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#L2020-1MG</td></tr><tr><td valign="middle" align="left">Dithiothreitol (DTT)</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#R0861, 11896744</td></tr><tr><td valign="middle" align="left">Tween-20</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#P9416-50ML</td></tr><tr><td valign="middle" align="left">RIPA buffer</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#R0278-500ML</td></tr><tr><td valign="middle" align="left">cOmplete, EDTA-free Protease Inhibitor Cocktail</td><td valign="middle" align="left">Merck/Roche</td><td valign="middle" align="left">Cat#11873580001</td></tr><tr><td valign="middle" align="left">Cycloheximide</td><td valign="middle" align="left">Biovision</td><td valign="middle" align="left">Cat#1041-1</td></tr><tr><td valign="middle" align="left">Actinomycin D</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#A1410-2MG</td></tr><tr><td valign="middle" align="left">SMG1 inhibitor</td><td valign="middle" align="left">ProbeChem</td><td valign="middle" align="left">Cat#PC-35788</td></tr><tr><td valign="middle" align="left"/><td valign="middle" align="left"/><td valign="middle" align="left"/></tr><tr><td valign="middle" align="left" colspan="3">Critical commercial assays</td></tr><tr><td valign="middle" align="left">RNeasy Plus Mini Kit</td><td valign="middle" align="left">Qiagen</td><td valign="middle" align="left">Cat#74134</td></tr><tr><td valign="middle" align="left">Absolutely RNA Minprep Kit</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#400800</td></tr><tr><td valign="middle" align="left">SuperScript IV First-Strand Synthesis System</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#18091050</td></tr><tr><td valign="middle" align="left">Q5 High-Fidelity DNA Polymerase</td><td valign="middle" align="left">NEB</td><td valign="middle" align="left">Cat#M0492L</td></tr><tr><td valign="middle" align="left">NEBuilder HiFi DNA Assembly Master Mix</td><td valign="middle" align="left">NEB</td><td valign="middle" align="left">Cat#E2621L</td></tr><tr><td valign="middle" align="left">GoTaq Taq G2 Green Master Mix</td><td valign="middle" align="left">Promega</td><td valign="middle" align="left">Cat#M7823</td></tr><tr><td valign="middle" align="left">Guide-it Long ssDNA Production System, 25 Rxns</td><td valign="middle" align="left">Takara Bio</td><td valign="middle" align="left">Cat#632644</td></tr><tr><td valign="middle" align="left">P3 Primary Cell 4D-Nucleofector Kit L (12 RXN)</td><td valign="middle" align="left">Lonza</td><td valign="middle" align="left">Cat#V4XP-3012</td></tr><tr><td valign="middle" align="left">Alt-R HDR Enhancer, 500 pL</td><td valign="middle" align="left">Integrated DNA Technologies</td><td valign="middle" align="left">Cat#226687070</td></tr><tr><td valign="middle" align="left">Qubit RNA Broad Range Assay Kit</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#Q10211</td></tr><tr><td valign="middle" align="left">RNA Screentape</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#5067-5576</td></tr><tr><td valign="middle" align="left">RNA Screentape Ladder</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#5067-5578</td></tr><tr><td valign="middle" align="left">RNA Screentape Buffer</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#5067-5577</td></tr><tr><td valign="middle" align="left">Loading tips, 10 pk</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#5067-5599</td></tr><tr><td valign="middle" align="left">DNA HS D1000 Screentape</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#5067-5584</td></tr><tr><td valign="middle" align="left">DNA HS D1000 Screentape Buffer</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#5067-5585</td></tr><tr><td valign="middle" align="left">DNA HS D1000 Screentape Ladder</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#5067-5587</td></tr><tr><td valign="middle" align="left">TruSeq Stranded mRNA Library Prep</td><td valign="middle" align="left">Illumina</td><td valign="middle" align="left">Cat#20020594</td></tr><tr><td valign="middle" align="left">Qubit RNA BR Assay Kit</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#Q10211</td></tr><tr><td valign="middle" align="left">Qubit dsDNA BR Assay Kit</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#Q32853</td></tr><tr><td valign="middle" align="left">BCA Protein Assay Kit</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#23225</td></tr><tr><td valign="middle" align="left">Immobilon Western Chemiluminescent HRP Substrate</td><td valign="middle" align="left">Merck</td><td valign="middle" align="left">Cat#WBKLS0500</td></tr><tr><td valign="middle" align="left">Lipofectamine LTX Reagent with Plus Reagent</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#A12621</td></tr><tr><td valign="middle" align="left">NEBNext Library Quant Kit for Illumina</td><td valign="middle" align="left">NEB</td><td valign="middle" align="left">Cat#E7630L</td></tr><tr><td valign="middle" align="left">AMPure XP Reagent for PCR Purification</td><td valign="middle" align="left">Beckman Coulter</td><td valign="middle" align="left">Cat#A63881</td></tr><tr><td valign="middle" align="left">NextSeq 500/550 High Output Kit v2.5 (75 Cycles)</td><td valign="middle" align="left">Illumina</td><td valign="middle" align="left">Cat#20024906</td></tr><tr><td valign="middle" align="left">Lipofectamine 2000 reagent</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#11668-027</td></tr><tr><td valign="middle" align="left">TransIT-LT1</td><td valign="middle" align="left">Mirus</td><td valign="middle" align="left">Cat#22043217</td></tr><tr><td valign="middle" align="left">dNTP Mix</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#R0192</td></tr><tr><td valign="middle" align="left">RiboLock RNAse inhibitor</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">Cat#EO0381</td></tr><tr><td valign="middle" align="left">AffinityScript Multi temperature Multiple Reverse Transcriptase</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#600107-51</td></tr><tr><td valign="middle" align="left">AffinityScript RT buffer</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#600100-52</td></tr><tr><td valign="middle" align="left">DTT</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#600100-53</td></tr><tr><td valign="middle" align="left">QuickChange Lightning Multi Site-Directed Mutagenesis Kit</td><td valign="middle" align="left">Agilent</td><td valign="middle" align="left">Cat#210513</td></tr><tr><td valign="middle" align="left"/><td valign="middle" align="left"/><td valign="middle" align="left"/></tr><tr><td valign="middle" align="left" colspan="3">Deposited data</td></tr><tr><td valign="middle" align="left"/><td valign="middle" align="left"/><td valign="middle" align="left"/></tr><tr><td valign="middle" align="left" colspan="3">Experimental models: Cell lines</td></tr><tr><td valign="middle" align="left">Human iPSC/iPSC-derived neuron: Bob (wild-type)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R41">Pawlowski et al., 2017</xref>)</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Human iPSC/iPSC-derived neuron: Cas9</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Human iPSC/iPSC-derived neuron: GFP-RBM3</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">HeLa</td><td valign="middle" align="left">ECACC</td><td valign="middle" align="left">Cat#93021013</td></tr><tr><td valign="middle" align="left">HEK293T (Lenti-X 293T)</td><td valign="middle" align="left">Clontech Takara</td><td valign="middle" align="left">Cat#632180</td></tr><tr><td valign="middle" align="left" colspan="3">Oligonucleotides</td></tr><tr><td valign="middle" align="left">Primers used in this study are listed in Table S1</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">HNRNPH siRNA#1 -5’ GGAAAUAGCUGAAAAGGCUdTdT 3’</td><td valign="middle" align="left">Microsynth</td><td valign="middle" align="left">Cat#2288931</td></tr><tr><td valign="middle" align="left">HNRNPH siRNA#2 -5’ GAGAGUACACAUUGAAAUUdTdT 3’</td><td valign="middle" align="left">Microsynth</td><td valign="middle" align="left">Cat#2276387</td></tr><tr><td valign="middle" align="left">Control siRNA</td><td valign="middle" align="left">Dharmacon</td><td valign="middle" align="left">Cat#D-001810-10-20</td></tr><tr><td valign="middle" align="left" colspan="3">Recombinant DNA</td></tr><tr><td valign="middle" align="left">Plasmid: pcDNA3-EGFP</td><td valign="middle" align="left">Addgene</td><td valign="middle" align="left">Cat#13031</td></tr><tr><td valign="middle" align="left">Plasmid: GFP-RBM3 repair template</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Plasmid: pLVPB-gCherry-PGK-BFP-2A- mCherry</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Lentiviral sgRNA cloning vector:pLVPB_U6_sgRNAv2fl_shortccdB_PGK_Puro_BFP</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R74">Metzakopian et al., 2017</xref>)</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Lentiviral sgRNA expression plasmids (all sgRNA sequences listed in Table S1 individually cloned into the cloning vector)</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Lentiviral packaging plasmid: psPax2</td><td valign="middle" align="left">Addgene</td><td valign="middle" align="left">Cat#12260</td></tr><tr><td valign="middle" align="left">Lentiviral packaging plasmid: pMD2.G</td><td valign="middle" align="left">Addgene</td><td valign="middle" align="left">Cat#12259</td></tr><tr><td valign="middle" align="left">Plasmid: RBM3 Minigene</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">Plasmid: delGGGG-RBM3 Minigene</td><td valign="middle" align="left">This study</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left" colspan="3">Software and algorithms</td></tr><tr><td valign="middle" align="left">Design and Analysis Software (v2.6.0)</td><td valign="middle" align="left">Thermo Fisher Scientific</td><td valign="middle" align="left">N/A</td></tr><tr><td valign="middle" align="left">FIJI (v2.1.0)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R77">Schindelin et al., 2012</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://fiji.sc/">https://fiji.sc/</ext-link></td></tr><tr><td valign="middle" align="left">MATLAB (R2020a)</td><td valign="middle" align="left">MathWorks</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://www.mathworks.com">https://www.mathworks.com</ext-link></td></tr><tr><td valign="middle" align="left">MAGeCK RRA</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R71">Li et al., 2014</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/mageck/">https://sourceforge.net/proj ects/mageck/</ext-link></td></tr><tr><td valign="middle" align="left">Bcl2fastq (v2.2.0)</td><td valign="middle" align="left">Illumina</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://emea.support.illumina.com/downloads/bcl2fastq-conversion-software-v2-20.html">https://emea.support.illumina.com/downloads/bcl2fastq-conversion-software-v2-20.html</ext-link></td></tr><tr><td valign="middle" align="left">Metascape (v3.5)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R80">Zhou et al., 2019</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://metascape.org/">https://metascape.org/</ext-link></td></tr><tr><td valign="middle" align="left">STRING (v11.5)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R79">Szklarczyk et al., 2020</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link></td></tr><tr><td valign="middle" align="left">nf-core/rnaseq pipeline (v3.3)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R75">Patel et al., 2021</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://nf-co.re/rnaseq">https://nf-co.re/rnaseq</ext-link></td></tr><tr><td valign="middle" align="left">nf-core/clipseq pipeline (v1.0.0)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R68">Ewels et al., 2020</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://nf-co.re/clipseq">https://nf-co.re/clipseq</ext-link></td></tr><tr><td valign="middle" align="left">DESeq2 (v3.15)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R73">Love et al., 2014</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link></td></tr><tr><td valign="middle" align="left">rmats2sashimiplot (v2.0.4)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R78">Shen et al., 2014</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://github.com/Xinglab/rmats2sashimiplot">https://github.com/Xinglab/rmats2sashimiplot</ext-link></td></tr><tr><td valign="middle" align="left">FastQC (v0.11.8)</td><td valign="middle" align="left">Babraham Institute</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></td></tr><tr><td valign="middle" align="left">STAR (v2.6.1b)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R67">Dobin et al., 2013</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">https://github.com/alexdobin/STAR</ext-link></td></tr><tr><td valign="middle" align="left">SAMtools (v1.9)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R71">Li et al., 2009</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="http://www.htslib.org/">http://www.htslib.org/</ext-link></td></tr><tr><td valign="middle" align="left">rMATS (v4.1.2)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R78">Shen et al., 2014</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://github.com/Xinglab/rmats-turbo">https://github.com/Xinglab/rmats-turbo</ext-link></td></tr><tr><td valign="middle" align="left">clipplotr (v1.0.0)</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R66">Chakrabarti et al., 2021</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://github.com/ulelab/clipplotr">https://github.com/ulelab/clipplotr</ext-link></td></tr><tr><td valign="middle" align="left">QGRS Mapper</td><td valign="middle" align="left">(<xref ref-type="bibr" rid="R69">Kikin et al., 2006</xref>)</td><td valign="middle" align="left"><ext-link ext-link-type="uri" xlink:href="https://bioinformatics.ramapo.edu/QGRS/index.php">https://bioinformatics.ramapo.edu/QGRS/index.php</ext-link></td></tr><tr><td valign="middle" align="left" colspan="3">Other</td></tr><tr><td valign="middle" align="left">MatTek glass-bottom dishes</td><td valign="middle" align="left">MatTek</td><td valign="middle" align="left">Cat#P35G-1.0-14-C</td></tr></tbody></table></table-wrap></sec><sec id="S9"><title>Human iPSC culture</title><p id="P24">Human induced pluripotent stem cells (iPSCs) with Neurogenin-2 (NGN2) transgene stably integrated into a ‘safe-harbour’ locus under doxycycline (Dox)-inducible promoter (<xref ref-type="bibr" rid="R76">Pawlowski et al., 2017</xref>) were maintained under feeder-free conditions in a 37°C, 5% CO<sub>2</sub> tissue culture incubator. They were cultured on vitronectin (3.3 μg/mL)-coated culture plates or glass-bottom dishes and fed every day with TeSR-E8 medium or every 2 days with StemFlex Medium. 0.5mM EDTA was used for routine dissociation to maintain colony growth. iPSCs were frozen in Cryostor Cs10 Cryopreservation.</p></sec><sec id="S10"><title>iPSCs differentiation into iPSC-derived neurons (i-neurons)</title><p id="P25">iPSCs were enzymatically detached and dissociated into single cells using Accutase and plated into GelTrex (1:100 dilution)-coated culture plates in TeSR-E8 medium supplemented with 10 μM Rho-associated protein kinase (ROCK) inhibitor. After 24 hours (day 1), TeSR-E8 medium was changed to DMEM/F12 medium with GlutaMAX, supplemented with 1x N-2 supplement, 1x Non-Essential Amino Acids, 50 nM 2-Mercaptoethanol, 100 U/mL Penicillin-Streptomycin, and 1 μg/mL Doxycycline Hyclate (Dox) (iN-1 medium). After 24 hours (day 2), the medium was replaced with the same medium as the previous day. From day 3 to day 6, the culture was fed daily with Neurobasal medium supplemented with 1x B-27 supplement (minus vitamin A), 1x GlutaMAX, 50 nM 2-Mercaptoethanol, 100 U/mL Penicillin-Streptomycin, and 1 μg/mL Dox, 10 ng/mL Neurotrophin-3 (NT-3), and 10 ng/mL Brain-derived neurotrophic factor (BDNF) (iN-2 medium). After day 6, the medium was changed every other day.</p><p id="P26">Cultures used for flow cytometry were prepared by dissociating day 4 iPSCs with Accutase and plating 80,000 cells per well in a 96-well culture plate pre-coated with GelTrex (1:100 dilution). The same feeding schedule as previously described was followed from day 5.</p><p id="P27">To prepare cultures for live fluorescent imaging, day 4 iPSCs were dissociated with Accutase and plated 10,000-20,000 cells/dish on 35 mm MatTek glass-bottom dishes pre-coated with 0.1 mg/mL poly-L-lysine and 10 μg/mL laminin in iN-2 medium with ROCK inhibitor. The same feeding schedule as previously described was followed from day 5.</p></sec><sec id="S11"><title>HeLa and HEK293T cell cultures and transfection</title><p id="P28">HeLa and HEK 293T cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)+ Ham’s F12 (1:1) supplemented with 10% fetal calf serum (FCS), penicillin (100 IU/mL), and streptomycin (100 μg/mL) and grown at 37°C and 5% CO2. Plasmid DNA transfections were performed with Lipofectamine 2000 (Thermo Fisher Scientific) and TransIT-LT1 (Mirus) according to the manufacturer’s instructions. For HNRNPH1 siRNA transfections, 250,000 HeLa cells were seeded in a 6-well plate and the next day cells were transfected with two siRNAs 10nM siRNA each (siRNA #1 + siRNA#2) using Lipofectamine 2000. After 24h, a second round of siRNA transfection is done in fresh medium with or without RBM3 minigene co-transfection. One set of the cells is moved to 32°C while the other set is kept at 37°C. 24h later, Medium is changed again with fresh medium with or without SMG1 inhibitor (1uM). After 24h, cells are harvested. SMG1 inhibitor treatment (1uM) and Cycloheximide (CHX) treatment (200ug/ml) was done for 24h before harvesting the cells.</p></sec><sec id="S12"><title>Plasmids, oligonucleotides, and guide RNAs</title><p id="P29">Plasmids: RBM3 minigene was cloned by amplifying genomic regions from exon 1-4 using forward primer - AAGAATTCATGTCCTCTGAAGAAGGAAAGC and reverse primer – TTTGCGGCCGCCTCTAGAGTAGCTGCGACCACGCC and then inserting in EcoRI-NotI sites in pcDNA3.1(+) vector backbone. Minigene Del GGGG mutant was generated using site directed mutagenesis (QuickChange Lightning Multi Site-Directed Mutagenesis Kit) using the primer-GTCGGGCAGCTTAGAGGAGTAGGAGAACTCAG. FLAG HNRNPH1 WT expression construct was generated by inserting HNRNPH1 coding sequence, obtained as a string synthesised (GeneArt, Thermo Fisher Scientific), in XbaI-NotI sites in pcDNA6F vector backbone. All primers, siRNAs and guide RNAs (sgRNAs) used in this study are listed in Table S1.</p><p id="P30">To prepare iPSC cDNA, RNA was purified from iPSC pellets using the RNeasy Mini kit and reverse transcribed into cDNA using the oligo(dT) primer and the SuperScript IV First-Strand Synthesis System. The following fragments were amplified by PCR using Q5 DNA Polymerase and the indicated templates and primers (see Table S1): a) The 5’ homology arm (1 kb sequence immediately upstream of RBM3 start codon) was amplified from iPSC cDNA using Primers Pr1 and Pr2; b)The GFP fragment was amplified from pcDNA3-EGFP using Primers Pr3 and Pr4; c) The 3’ homology arm (start codon and 1 kb sequence at it immediate downstream) was amplified from iPSC cDNA using Primers Pr5 and Pr6; d) the origin of replication and ampicillin-resistant gene were amplified using Primers Pr7 and Pr8.</p><p id="P31">The repair template plasmid for CRISPR knocked in of GFP to the N-terminal of the RBM3 coding region (GFP-RBM3 repair template) was generated by assembling Fragments a-b-c-d in the indicated order using NEBuilder. Plasmids were validated by Sanger sequencing. Single-stranded DNA (ssDNA) were subsequently synthesized from these repair template plasmids to improve CRISPR knock-in efficiency using Guide-it Long ssDNA Production System with Primers Pr9 and Pr10 according to manufacturer instructions.</p><p id="P32">The 19-nucleotide (nt) guide RNA (gRNA) RBM3-N gRNA#1 (5’-CUGCCAUGUCCUCUGAAGA-3’) and #2 (5’-UUUCCUUCUUCAGAGGACA-3’) followed by the protospacer adjacent motif (PAM) targeting the region adjacent to the RBM3 start codon were resuspended in water to the concentration of 4 μg/μL.</p></sec><sec id="S13"><title>Generation of GFP-RBM3 iPSCs by CRISPR</title><p id="P33">Half a million wild-type iPSCs were electroporated with Cas9 protein, RBM3 gRNAs and GFP-RBM3 repair template using Lonza Nucleofector Technology according to manufacturer instructions. Briefly, Cas9-RNP complex mixture containing 0.2 μL 3 M NaCl, 1 μL RBM3-N gRNA#1, 1 μL RBM3-N gRNA#2, 1 μL Cas9 protein (HiFi Cas9 nuclease V3, 10 μg/μL) were assembled and incubated at room temperature for 45 min. 0.5 million iPSCs were resuspended with the nucleofector solution (90 μL P3 solution and 20 μL supplement). 3 μL of the repair template ssDNA (4 μg/μL) were added to the pre-assembled Cas9-RNP, mixed with the iPSC suspension, and transferred to the Nucleocuvette Vessels. Placed the vessel into the nucleofector unit and started the program to complete electroporation. Immediately after, the electroporated cells were gently transferred to the 4 mL pre-warmed StemFlex medium supplemented with 10 μM ROCK inhibitor and 40 μL homology-directed repair (HDR) enhancer and plated into 2 vitronectin-coated wells in a 6-well plate. The cells were then incubated at 32 °C for 48 h. The following day after electroporation, the medium was replaced with StemFlex medium and replaced every other day. When reaching 70-80% confluency, cells in one well were frozen in Cryostor Cs10 Cryopreservation at -80 °C and those in the other were detached and dissociated with Accutase. Isolated iPSCs were plated in a vitronectin-coated 96-well plate in StemFlex medium supplemented with 10 μM ROCK inhibitor, with 30-50 cells per well. From the next day, the iPSCs were fed with StemFlex medium every other day until confluent. Confluent wells were dissociated and half of the cells were subject to flow cytometry measurement (see Flow cytometry) to determine the GFP intensity of iPSCs in each well. 500-750 cells from each of the wells with GFP-positive cells were plated in a vitronectin-coated 10 cm petri dish in StemFlex medium supplemented with 10 μM ROCK inhibitor. From the next day, the hiPSCs were fed with StemFlex medium every other day until colonies were formed (1-2 weeks). Imaged with a wild-field fluorescent microscope, GFP-positive colonies were picked by gentle aspirating with P1000 pipette tips and transferred to a well in round-bottom 96-well plates with 200 μL StemFlex medium with 10 μM ROCK inhibitor and 100 U/mL Penicillin-Streptomycin per well. Once finished colony picking, each well was split into 2 vitronectin-coated flat-bottom 96-well plates by gentle pipetting to break colonies into small clusters and transferring 100 μL cell suspension in each well into a well in new plates. Each well was fed StemFlex medium every other day until the majority of the wells reached 50-60% confluency. Genomic DNA of individual colonies in one of the duplicated plates was extracted (see Genomic DNA extraction) and PCR-genotyped using GoTaq Taq G2 Green Master Mix and primer pairs Pr11/12, Pr11/14, and Pr12/13. The correctly genotyped clones in the corresponding second plates were expanded in 6-well plates to be further validated by Sanger sequencing. Sequence-verified clones were aliquoted and frozen at -80 °C.</p></sec><sec id="S14"><title>Genomic DNA extraction</title><p id="P34">iPSCs were detached using Accutase and pelleted by centrifugation at 250 g for 5 min. After removing the supernatant, 50 μL (each well of a 96-well plate) or 5-10 μL (every 1000 iPSCs) lysis buffer (and 1:40 freshly added Proteinase K) was added to the pellet and lysed at 55 °C overnight in a shaker. The next day, 10% volume of 3M sodium acetate (pH 5.2) and an equal volume of isopropanol were added to the lysate and mixed by brief vortexing. Genomic DNA was pelleted by 15 min centrifugation at maximum speed, followed by two washes with 200-1000 μL of 80% ethanol. After the last centrifugation to remove the residual ethanol, pellets were left at room temperature to air dry, and resuspended in 50-500 μL TE buffer (10 mM Tris-HCl, pH 8.0 and 0.1 mM EDTA).</p></sec><sec id="S15"><title>Western blotting</title><p id="P35">Protein concentrations of lysates were determined by BCA assay following the manufacturer’s instruction. Samples were diluted with Laemmli protein sample buffer with 100 mM DTT. 10-15 μg protein was loaded into each well in pre-cast 12% gels or 4-15% gradient gels and ran at 125 V. Proteins were transferred to a 0.2 μm nitrocellulose membrane at 70 V for 2 h in a wet blot system. Membranes were blocked with 5% BSA or 5% non-fat milk in 1x TBS-T for 1 h rotating at room temperature. The primary antibody solution was incubated overnight at 4°C while rotating. The next day, membranes were washed three times with 1x TBS-T, then incubated for 1 h in secondary antibody solution (1:10,000 in 5% BSA or 5% non-fat milk in 1x TBS-T) and washed three times with 1x TBS-T before adding HRP chemiluminescent substrate to develop on a ChemiDox MP Imaging System or directly on LI-COR Odyssey CLx Primary and secondary antibodies were used in the following concentrations: rabbit anti-RBM3 (1:1000), mouse anti-Cas9 (1:1000), mouse anti-GAPDH (1:2000), mouse anti-Cas9 (1:2000), rabbit anti-HNRNPH1 (1:1000), mouse anti-FLAG (1:2000), rabbit anti-SmD3 (1:1000), donkey anti-rabbit 680LT (1:10000), donkey anti-mouse 680LT (1:10000), donkey anti-rabbit 800CW (1:10000), donkey anti-mouse 800CW (1:10000), goat anti-rabbit and goat anti-mouse HRP conjugated secondary antibodies (1:10000, Biorad).</p></sec><sec id="S16"><title>Lentiviral production</title><p id="P36">96-well plates or T75 flasks pre-coated with 25 μg/ml PLL at 37°C overnight, followed by 3 times washes with distilled water and left to dry in tissue culture hoods. HEK293FT were plated at 10<sup>6</sup> cells/cm<sup>2</sup> density and incubated at 37°C overnight. Lentiviral expression and packaging plasmids were transfected using Lipofectamine LTX. For each well of a 96-well plate (upscale proportionally for T75 flask transfection), Mix A: 20 μL Opti-MEM, 19.12 ng psPax2, 12.5 ng pMD2.G, 25 ng expression plasmid, 0.1 μL Plus Reagent; Mix B: 5 μL Opti-MEM, 0.3 μL Lipofectamine LTX were assembled and incubated at room temperature for 20 min before adding to the HEK293FT cultures. After 24h, replace with fresh media and check for BFP expression. Viruses were harvested 72h post-transfection by centrifuging at 6000g at 4°C overnight. Resuspend pellets with PBS and freeze at - 80°C for storage.</p></sec><sec id="S17"><title>Flow cytometry</title><p id="P37">Dissociated cells were resuspended in culture media in 96-well plates and fluorescent intensities of GFP, mCherry and/or BFP were measured at room temperature with a CytoFLEX S System (Beckman Coulter) and CytExpert (v2.4) Program. Acquired data were analysed with FlowJo (v10.7.2).</p></sec><sec id="S18"><title>Imaging of i-neurons</title><p id="P38">I-neurons cultured at low density on 35mm glass bottom dishes were imaged in phenol red-free iN-2 media (minimise autofluorescence) in OkoLab temperature-controlled chamber. Cells were imaged at two temperatures: 37°C (control and rewarmed) and 32°C (cooled) with 5% CO<sub>2</sub>. Cells were imaged with a custom-built wide-field microscope in Epi fluorescence mode with a 100x oil TIRF objective (Olympus). BFP was excited with a 504 nm laser at 10 mW, and GFP with a 488 nm laser at 5 mW. Both channels were imaged simultaneously and separated with OptoSplit III System (Cairn Research) and a Prime BSI camera (Photometrics).</p></sec><sec id="S19"><title>RBM3 CRISPR knockout screen</title><p id="P39">Both clones of GFP-RBM3 iPSCs were differentiated in GelTrex-coated T75 flasks. The total number of i-neurons used for each clone in each replicate was approximately 60,000,000 to ensure sufficient copies of individual sgRNAs could be obtained from the pool. 4 days post differentiation, the cultures were transduced with a whole-genome sgRNA lentiviral library (399 non-targeting sgRNAs and 91138 sgRNAs targeting 18466 genes across the human genome), co-expressing a BFP fluorescent reporter to indicate successfully transduced cells. The viral titer was determined in pilot experiments, resulting in 20% of the i-neurons becoming BFP-positive on day 18 to minimise multiple sgRNA entries into a single cell. I-neurons at 14, 15 or 16 days post differentiation (or 11, 12, 13 days post-transduction) were cooled at 32°C for 72h before dissociation with 20 min Accutase and 10 min Trypsin-EDTA incubation, followed by fluorescence-activated cell sorting (FACS). GFP intensity of all BFP-positive cells was manually separated into 4 quartiles, and only cells with the GFP intensity falling in the top or the bottom quartile were collected in separate tubes and their genomic DNA was extracted (see Genomic DNA extraction) immediately after. Around 3,000,000 i-neurons were collected in the low GFP or high GFP tube for each clone in each replicate.</p><p id="P40">Purified DNA was sequenced to identify sgRNAs enriched in high or low GFP populations. The sequencing library was created in a two-stage PCR reaction. The first stage amplifies the enriched gRNA cassettes: 2 μg DNA, 1.5 μL Forward Primer (10 μM), 1.5 μL Reverse Primer (10 μM), 25 μL NEB Q5 High-Fidelity 2x Master Mix in a 50 μL reaction. The PCR condition was: 98C for 30 sec, 25 cycles of (98C for 10 sec, 62C for 30 sec, 72C for 15 sec), and 72C for 2 min. PCR product was purified using Ampure XP Beckman magnetic beads and diluted to 200 pg/μL. The second PCR attached the Illumina adaptors and barcodes: 1 μL PCR product from the first reaction, 0.75 μL Forwards Primer (20 uM), 0.75 μL Reverse Primer (20 uM), 10 μL Roche 2X KAPA HiFi ReadyMix in a 20 μL reaction. The PCR condition was: 95C for 3 min, 9 cycles of (98C for 20 sec, 66C for 15 sec, 72C for 20 sec), and 72C for 1 min. PCR products were purified using Ampure XP Beckman magnetic beads and eluted in 35 μL TE buffer. PCR products were quantified with NEBNext Library Quant Kit for Illumina. The library was run on an Illumina NextSeq 550, using an Illumina 75 cycle, high output kit at 1.4 pM.</p></sec><sec id="S20"><title>Arrayed CRISPR target validation</title><p id="P41">Inserts containing the candidate gene targeting sgRNA (1-3 sgRNAs per gene) sequences and non-targeting sgRNA sequences (see Table S1) were cloned into lentiviral expression vector pLVPB-U6-sgRNAv2fl_shortccdB_PGK_Puro_BFP linearised with BbsI, which removed the suicide ccdB cassette. The sgRNA expression plasmids were verified by Sanger sequencing and used to generate lentiviral particles (see Lentiviral production) in a 96-well array format. GFP-RBM3 Clone 1 iPSCs at 4 days after differentiation in 96-well plates were transduced with the arrayed lentiviral library at a viral concentration pre-determined in pilot experiments to obtain maximal transduction efficiency. 15 days post differentiation, GFP-RBM3 i-neurons were either cooled at 32°C for 72h or continue to grow at 37°C. On day 18, BFP and GFP intensity of the transduced cultures were measured using flow cytometry (see Flow cytometry).</p></sec><sec id="S21"><title>RNA-Seq</title><p id="P42">Four biological replicates of WT i-neurons in control (37 °C) and cooled (72 h at 32 °C, day 15-18) were included in this study. Total RNA was extracted with RNeasy Plus Mini Kit. RNA concentrations of individual samples were measured using Qubit RNA Broad Range Assay Kit and their integrity was determined using Agilent TapeStation System. The library was prepared using Illumina TruSeq Stranded mRNA Library Prep following the manufacturer’s instructions and sequenced paired-end 150 bp on Novaseq.</p></sec><sec id="S22"><title>RT-PCR and qRT-PCR</title><p id="P43">RNA of i-neurons, HeLa and HEK293T cells in 3 or more biological replicates was extracted using the RNeasy Plus Mini kit or Absolute RNA miniprep kit and reverse transcribed into cDNA using random hexamers and the SuperScript IV First-Strand Synthesis System or AffinityScript Multiple Temperature Reverse Transcriptase. Briefly, to reverse transcribe RNA into cDNA, 1-2 μg of isolated RNA were incubated with random hexamers (900ng) in a total volume of 67 μl in DEPC water at 65 °C for 5 minutes and then for 10 minutes at room temperature. Then, the mixtures were separated into 2 parts – RT and no-RT control samples (33.5 μl each). To this 13.5 μl master mix were added to supplement 1x reverse transcriptase buffer (Agilent), 10 mM DTT (Agilent), 400 μM dNTPs (Thermo Scientific), 40 units RiboLock RNase inhibitor (Thermo Scientific) and 1 reaction equivalent AffinityScript Multiple Temperature Reverse Transcriptase (Agilent). The RT enzyme was absent in the no-RT condition. The samples were then incubated at 65 °C for 1 hour followed by heat-inactivation at 75 °C for 20 minutes. For RT-PCR, 20-40ng cDNA was amplified using GoTaq Polymerase mix using either RBM3 Exon 2-4 primers or RBM3 minigene specific primers (See also Table S1). Quantification of the bands on agarose gels was done using FIJI software. Percent spliced in (PSI) indexes of RBM3 poison exon (PE) are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrows) isoforms visualised in agarose gels:</p><list list-type="simple" id="L1"><list-item><label>a)</label><p id="P44">One PE-included isoform is detected: (I<sub>Inc</sub>/L<sub>Inc</sub>) / (I<sub>Inc</sub>/L<sub>Inc</sub> + I<sub>skip</sub>/L<sub>skip</sub>), or</p></list-item><list-item><label>b)</label><p id="P45">Two PE-included isoforms are detected: (I<sub>Inc1</sub>/L<sub>Inc1</sub> + I<sub>Inc2</sub>/L<sub>Inc2</sub>) / (I<sub>Inc1</sub>/L<sub>Inc1</sub> + I<sub>Inc2</sub>/L<sub>Inc2</sub> + I<sub>skip</sub>/L<sub>skip</sub>)</p></list-item></list><p id="P46">Where I<sub>Inc</sub> = Intensity of PE-included isoform, L<sub>Inc</sub> = length of PE-included isoform in base pairs, I<sub>Inc</sub> = Intensity of PE-skipped isoform, L<sub>skip</sub> = length of PE-skipped isoform in base pairs.</p><p id="P47">For qRT-PCR, cDNA of each sample (diluted 10-1000 times) was mixed with SYBR Green PCR Master Mix and PCR primers in 4 technical replicates in 384-well plates. Reactions were performed in a QuantStudio Real-Time PCR system (ThermoFisher Scientific). Analysis was performed with Design and Analysis Software (v2.6.0, ThermoFisher Scientific). PSI indexes of RBM3 PE are ratios of the normalised expression levels between RBM3 Exon 3a amplicon and RBM3 Exon 3 (or Exon 4-5) amplicon.</p></sec><sec id="S23"><title>Data analysis</title><sec id="S24"><title>Image quantification of GFP-RBM3 iPSCs and i-neurons</title><p id="P48">Regions with single cells were cropped from the full-size images with a custom-made program. Then, each single cell image was analysed with a custom-made MatLab pipeline. Briefly, two channels were used for analysis: BFP and GFP. BFP is expressed by the lentivirus as a reporter to indicate transduced cells and it is used to define the cell boundary. Nuclei were defined as areas where GFP is uniformly expressed at higher intensities, as RBM3 is predominantly nuclear. This was achieved by applying automatic global Otsu’s threshold to the GFP channel. Average GFP channel intensities (total intensities divided by corresponding areas were calculated in the somas, nuclei, and cytoplasm (regions outside of nuclei but within the soma).</p></sec><sec id="S25"><title>Whole-genome CRISPR screen next-generation sequencing analysis</title><p id="P49">21nt long sequencing reads were exported from bcl files using bcl2fastq v2.2.0. These reads were counted by converting them to k-mers and mapping them to a set of 91,536 valid CRISPR library 20nt gRNA sequences. Reads without an exact match in the library were discarded. After merging the sample counts into a count table, the samples were inspected for proper gRNA infection and coverage. With all the samples passing QC, the MAGeCK RRA (<xref ref-type="bibr" rid="R72">Li et al., 2014</xref>) was used to perform gene essentiality and enrichment inference. To run MAGeCK, we used the paired samples option, which contained the sorted samples: low GFP sample in control and high GFP samples in the treatment and a set of non-targeting gRNAs as controls. Functional and network analyses of top RBM3 regulator candidates with FDR&lt;0.05 were performed with Metascape (<xref ref-type="bibr" rid="R80">Zhou et al., 2019</xref>) and STRING (<xref ref-type="bibr" rid="R79">Szklarczyk et al., 2020</xref>).</p></sec></sec><sec id="S26"><title>RNA-Seq analysis</title><p id="P50">Fastq files of sequencing reads were processed directly with the nf-core (<xref ref-type="bibr" rid="R68">Ewels et al., 2020</xref>) rnaseq pipeline (v3.3) (<xref ref-type="bibr" rid="R75">Patel et al., 2021</xref>), mapped to hg38 genome with the gencode v38 annotation (GRCh38.p13). A gene expression quantification table was generated from the salmon output gene counts using the star_salmon aligner option within the nf-core/rnaseq pipeline. Differential expression analysis was performed using DESeq2 (v3.15). Grouped sashimi plots to visualise alternative splicing of RBM3 mRNA between control and cooled i-neurons were generated using rmats2sashimiplot (v2.0.4) and BAM files.</p></sec><sec id="S27"><title>ENCODE Project data analysis</title><p id="P51">RBM3 TPM values in RNA-Seq experiments following targeted CRISPR editing in HepG2 and K562 cell lines, together with the matching control samples, were extracted from the publicly available HNRNPH1 (ENCFF039DFP, ENCFF713MXN, ENCFF616BYI, ENCFF586TGE, ENCFF293ODK, ENCFF266YWO, ENCFF053QJC, ENCFF200BWY), SNRNP70 (ENCFF367WUN, ENCFF058OGQ, ENCFF873KLR, ENCFF311ACC), PUF60 (ENCFF682SFK, ENCFF461EMF, ENCFF585BAL, ENCFF643OYR) and KPNB1 (ENCFF819AUU, ENCFF628VDB, ENCFF565TSG, ENCFF073IFA)-knockdown datasets of the ENCODE Project.</p><p id="P52">To perform splicing analysis on RBM3 mRNA in control and HNRNPH1 knocked-down HepG2 and K562 cells. Raw Fastq files were downloaded from the European Nucleotide Archive (ENA). Fastq files were processed through FastQC (v0.11.8) for quality control. The data quality of each Fastq file was reviewed manually. Reads were mapped to GRCh38.p13 human reference genome by STAR (v2.6.1b). Alignment results were sorted by the coordinate. Output BAM files were indexed by SAMtools (v1.9).</p><p id="P53">Splicing analysis was performed using rMATS (v4.1.2). Control and knockdown samples were grouped separately to serve as inputs of rMATS. The gene annotation file (GENECODE Human Release 34, GRCh38.p13) was used for analysis. Inclusion levels and FDR values of RBM3 Exon 3a relative to Exon 3 and 4 in the skipped exon output tables (SE.MATS.JCEC) were used to generate bar graphs indicating RBM3 Exon 3a inclusion levels (see Table S3 for corresponding entries). Grouped sashimi plots to visualise alternative splicing of RBM3 Exon 3 and 4 between control and HNRNPH1 knocked down samples were generated using rmats2sashimiplot (v2.0.4) and BAM files.</p></sec><sec id="S28"><title>HNRNPH1 public iCLIP analysis</title><p id="P54">Sequence fastq files from public HNRNPH1 iCLIP datasets from HEK293T cells were accessed from ArrayExpress with accession numbers ERR2201859 &amp; ERR2201860 (<xref ref-type="bibr" rid="R5">Braun et al., 2018</xref>). Samples were processed with the nf-core/clipseq pipeline v1.0.0 (<xref ref-type="bibr" rid="R68">Ewels et al., 2020</xref>), mapped to hg38 genome with the gencode v38 annotation to obtain crosslink counts. Crosslink signal was visualised with library size normalisation and rollmean smoothing (window 5) with clipplotr (<xref ref-type="bibr" rid="R66">Chakrabarti et al., 2021</xref>) between exons 3 and 4 of RBM3 (chrX:48575560-48576419:+). RNA G4 prediction was performed with QGRS Mapper using default settings (<xref ref-type="bibr" rid="R69">Kikin et al., 2006</xref>).</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figures</label><media xlink:href="EMS156495-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d83aAdWbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S29"><title>Acknowledgements</title><p>The authors thank Sandeep Rajan and Stefanie Foskolou (University of Cambridge) for technical assistance, Oliver Muehlemann (University of Bern) for sharing the SMG1 inhibitor, Alessio Vagnoni (King’s College London) for HEK293T cells, Cambridge CRUK Core Genomics Facility and CIMR Flow Cytometry Core Facility for services. This work is supported by a Sir Henry Wellcome Postdoctoral Fellowship [215943/Z/19/Z] (to J.Q.L.), an Open Targets grant [OTAR2054] (to S.P., S.F.F., E.M., G.R.M.), the UK Dementia Research Institute (to D.K., S.M., N.P., J.U., E.M., M.-D.R., G.R.M.), which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council (MRC), Alzheimer’s Society and Alzheimer’s Research UK. This research was funded in whole, or in part, by the Wellcome Trust and MRC. For the purpose of open access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</p></ack><fn-group><fn id="FN1" fn-type="con"><p id="P55"><bold>Author Contributions</bold></p><p id="P56">Conceptualization, J.Q.L., E.M., M.-D.R. and G.R.M.; Methodology, J.Q.L., D.K., and S.P.; Investigation: J.Q.L., D.K., S.P., S.M., S.F.F., J.M.Z. and J.L.F.; Formal analysis: S.M., N.P., F.C.Y.L. and J.K.; Supervision, J.U., E.M., M.-D.R. and G.R.M.; J.Q.L. and D.K. wrote the manuscript with inputs from other authors.</p></fn><fn id="FN2" fn-type="conflict"><p id="P57"><bold>Declaration of interests</bold></p><p id="P58">S.P. is now an AstraZeneca employee.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>AA</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>PG</given-names></name><name><surname>Buonamici</surname><given-names>S</given-names></name></person-group><article-title>Targeting splicing abnormalities in cancer</article-title><source>Curr Opin Genet Dev</source><year>2018</year><volume>48</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2017.10.010</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ávila-Gómez</surname><given-names>P</given-names></name><name><surname>Vieites-Prado</surname><given-names>A</given-names></name><name><surname>Dopico-López</surname><given-names>A</given-names></name><name><surname>Bashir</surname><given-names>S</given-names></name><name><surname>Fernández-Susavila</surname><given-names>H</given-names></name><name><surname>Gubern</surname><given-names>C</given-names></name><name><surname>Pérez-Mato</surname><given-names>M</given-names></name><name><surname>Correa-Paz</surname><given-names>C</given-names></name><name><surname>Iglesias-Rey</surname><given-names>R</given-names></name><name><surname>Sobrino</surname><given-names>T</given-names></name><etal/></person-group><article-title>Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome</article-title><source>Brain Commun</source><year>2020</year><volume>2</volume><elocation-id>fcaa078</elocation-id><pub-id pub-id-type="doi">10.1093/braincomms/fcaa078</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bampton</surname><given-names>A</given-names></name><name><surname>Gittings</surname><given-names>LM</given-names></name><name><surname>Fratta</surname><given-names>P</given-names></name><name><surname>Lashley</surname><given-names>T</given-names></name><name><surname>Gatt</surname><given-names>A</given-names></name></person-group><article-title>The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis</article-title><source>Acta Neuropathol</source><year>2020</year><volume>140</volume><fpage>599</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1007/s00401-020-02203-0</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastide</surname><given-names>A</given-names></name><name><surname>Peretti</surname><given-names>D</given-names></name><name><surname>Knight</surname><given-names>JRP</given-names></name><name><surname>Grosso</surname><given-names>S</given-names></name><name><surname>Spriggs</surname><given-names>RV</given-names></name><name><surname>Pichon</surname><given-names>X</given-names></name><name><surname>Sbarrato</surname><given-names>T</given-names></name><name><surname>Roobol</surname><given-names>A</given-names></name><name><surname>Roobol</surname><given-names>J</given-names></name><name><surname>Vito</surname><given-names>D</given-names></name><etal/></person-group><article-title>RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3</article-title><source>Curr Biol</source><year>2017</year><volume>27</volume><fpage>638</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2017.01.047</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>S</given-names></name><name><surname>Enculescu</surname><given-names>M</given-names></name><name><surname>Setty</surname><given-names>ST</given-names></name><name><surname>Cortés-López</surname><given-names>M</given-names></name><name><surname>de Almeida</surname><given-names>BP</given-names></name><name><surname>Sutandy</surname><given-names>FXR</given-names></name><name><surname>Schulz</surname><given-names>L</given-names></name><name><surname>Busch</surname><given-names>A</given-names></name><name><surname>Seiler</surname><given-names>M</given-names></name><name><surname>Ebersberger</surname><given-names>S</given-names></name><etal/></person-group><article-title>Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><elocation-id>3315</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05748-7</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Hite</surname><given-names>ZL</given-names></name><name><surname>Lyu</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Gregorich</surname><given-names>ZR</given-names></name><name><surname>Messer</surname><given-names>AE</given-names></name><name><surname>McIlwain</surname><given-names>SJ</given-names></name><name><surname>Marston</surname><given-names>SB</given-names></name><name><surname>Kohmoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Temperature-sensitive sarcomeric protein post-translational modifications revealed by top-down proteomics</article-title><source>J Mol Cell Cardiol</source><year>2018</year><volume>122</volume><fpage>11</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2018.07.247</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caputi</surname><given-names>M</given-names></name><name><surname>Zahler</surname><given-names>AM</given-names></name></person-group><article-title>Determination of the RNA Binding Specificity of the Heterogeneous Nuclear Ribonucleoprotein (hnRNP) H/H′/F/2H9 Family *</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>43850</fpage><lpage>43859</lpage><pub-id pub-id-type="doi">10.1074/jbc.M102861200</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>R</given-names></name></person-group><article-title>A meta-analysis of the effects of therapeutic hypothermia in adult patients with traumatic brain injury</article-title><source>Crit Care</source><year>2019</year><volume>23</volume><elocation-id>396</elocation-id><pub-id pub-id-type="doi">10.1186/s13054-019-2667-3</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chip</surname><given-names>S</given-names></name><name><surname>Zelmer</surname><given-names>A</given-names></name><name><surname>Ogunshola</surname><given-names>OO</given-names></name><name><surname>Felderhoff-Mueser</surname><given-names>U</given-names></name><name><surname>Nitsch</surname><given-names>C</given-names></name><name><surname>Bührer</surname><given-names>C</given-names></name><name><surname>Wellmann</surname><given-names>S</given-names></name></person-group><article-title>The RNA-binding protein RBM3 is involved in hypothermia induced neuroprotection</article-title><source>Neurobiol Dis</source><year>2011</year><volume>43</volume><fpage>388</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2011.04.010</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>MY</given-names></name><name><surname>Rooke</surname><given-names>N</given-names></name><name><surname>Turck</surname><given-names>CW</given-names></name><name><surname>Black</surname><given-names>DL</given-names></name></person-group><article-title>hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells</article-title><source>Mol Cell Biol</source><year>1999</year><volume>19</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.1.69</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornette</surname><given-names>L</given-names></name></person-group><article-title>Therapeutic hypothermia in neonatal asphyxia</article-title><source>Facts Views Vis Obgyn</source><year>2012</year><volume>4</volume><fpage>133</fpage><lpage>139</lpage></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Marabti</surname><given-names>E</given-names></name><name><surname>Abdel-Wahab</surname><given-names>O</given-names></name></person-group><article-title>Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease</article-title><source>Trends Mol Med</source><year>2021</year><volume>27</volume><fpage>643</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2021.04.005</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><collab>ENCODE Project Consortium</collab><article-title>An integrated encyclopedia of DNA elements in the human genome</article-title><source>Nature</source><year>2012</year><volume>489</volume><fpage>57</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature11247</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgakopoulos-Soares</surname><given-names>I</given-names></name><name><surname>Parada</surname><given-names>GE</given-names></name><name><surname>Wong</surname><given-names>HY</given-names></name><name><surname>Medhi</surname><given-names>R</given-names></name><name><surname>Furlan</surname><given-names>G</given-names></name><name><surname>Munita</surname><given-names>R</given-names></name><name><surname>Miska</surname><given-names>EA</given-names></name><name><surname>Kwok</surname><given-names>CK</given-names></name><name><surname>Hemberg</surname><given-names>M</given-names></name></person-group><article-title>Alternative splicing modulation by G-quadruplexes</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>2404</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-30071-7</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillentine</surname><given-names>MA</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Hoekzema</surname><given-names>K</given-names></name><name><surname>Rosenfeld</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>CN</given-names></name><name><surname>De Vries</surname><given-names>BBA</given-names></name><name><surname>Vissers</surname><given-names>LELM</given-names></name><name><surname>Nordenskjold</surname><given-names>M</given-names></name><etal/></person-group><article-title>Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders</article-title><source>Genome Med</source><year>2021</year><volume>13</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-021-00870-6</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotic</surname><given-names>I</given-names></name><name><surname>Omidi</surname><given-names>S</given-names></name><name><surname>Fleury-Olela</surname><given-names>F</given-names></name><name><surname>Molina</surname><given-names>N</given-names></name><name><surname>Naef</surname><given-names>F</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><article-title>Temperature regulates splicing efficiency of the cold-inducible RNA-binding protein gene Cirbp</article-title><source>Genes Dev</source><year>2016</year><volume>30</volume><fpage>2005</fpage><lpage>2017</lpage><pub-id pub-id-type="doi">10.1101/gad.287094.116</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haltenhof</surname><given-names>T</given-names></name><name><surname>Kotte</surname><given-names>A</given-names></name><name><surname>De Bortoli</surname><given-names>F</given-names></name><name><surname>Schiefer</surname><given-names>S</given-names></name><name><surname>Meinke</surname><given-names>S</given-names></name><name><surname>Emmerichs</surname><given-names>A-K</given-names></name><name><surname>Petermann</surname><given-names>KK</given-names></name><name><surname>Timmermann</surname><given-names>B</given-names></name><name><surname>Imhof</surname><given-names>P</given-names></name><name><surname>Franz</surname><given-names>A</given-names></name><etal/></person-group><article-title>A Conserved Kinase-Based Body-Temperature Sensor Globally Controls Alternative Splicing and Gene Expression</article-title><source>Mol Cell</source><year>2020</year><volume>78</volume><fpage>57</fpage><lpage>69</lpage><elocation-id>e4</elocation-id><pub-id pub-id-type="doi">10.1016/j.molcel.2020.01.028</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havens</surname><given-names>MA</given-names></name><name><surname>Hastings</surname><given-names>ML</given-names></name></person-group><article-title>Splice-switching antisense oligonucleotides as therapeutic drugs</article-title><source>Nucleic Acids Res</source><year>2016</year><volume>44</volume><fpage>6549</fpage><lpage>6563</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw533</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name></person-group><article-title>Nonsense-Mediated mRNA Decay: Degradation of Defective Transcripts Is Only Part of the Story</article-title><source>Annu Rev Genet</source><year>2015</year><volume>49</volume><fpage>339</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-112414-054639</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmen</surname><given-names>TM</given-names></name><name><surname>Lyden</surname><given-names>PD</given-names></name></person-group><article-title>Hypothermia after acute ischemic stroke</article-title><source>J Neurotrauma</source><year>2009</year><volume>26</volume><fpage>387</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1089/neu.2008.0574</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofweber</surname><given-names>M</given-names></name><name><surname>Dormann</surname><given-names>D</given-names></name></person-group><article-title>Friend or foe—Post-translational modifications as regulators of phase separation and RNP granule dynamics</article-title><source>J Biol Chem</source><year>2019</year><volume>294</volume><fpage>7137</fpage><lpage>7150</lpage><pub-id pub-id-type="doi">10.1074/jbc.TM118.001189</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>H-R</given-names></name><name><surname>Lutz</surname><given-names>K</given-names></name><name><surname>Kerstetter</surname><given-names>RA</given-names></name><name><surname>Michael</surname><given-names>TP</given-names></name><name><surname>McClung</surname><given-names>CR</given-names></name></person-group><article-title>Type II protein arginine methyltransferase 5 (PRMT5) is required for circadian period determination in Arabidopsis thaliana</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><fpage>21211</fpage><lpage>21216</lpage><pub-id pub-id-type="doi">10.1073/pnas.1011987107</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Harvey</surname><given-names>SE</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name></person-group><article-title>RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF</article-title><source>Genes Dev</source><year>2017</year><volume>31</volume><fpage>2296</fpage><lpage>2309</lpage><pub-id pub-id-type="doi">10.1101/gad.305862.117</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iserman</surname><given-names>C</given-names></name><name><surname>Desroches Altamirano</surname><given-names>C</given-names></name><name><surname>Jegers</surname><given-names>C</given-names></name><name><surname>Friedrich</surname><given-names>U</given-names></name><name><surname>Zarin</surname><given-names>T</given-names></name><name><surname>Fritsch</surname><given-names>AW</given-names></name><name><surname>Mittasch</surname><given-names>M</given-names></name><name><surname>Domingues</surname><given-names>A</given-names></name><name><surname>Hersemann</surname><given-names>L</given-names></name><name><surname>Jahnel</surname><given-names>M</given-names></name><etal/></person-group><article-title>Condensation of Ded1p Promotes a Translational Switch from Housekeeping to Stress Protein Production</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>818</fpage><lpage>831</lpage><elocation-id>e19</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.009</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>TC</given-names></name><name><surname>Manole</surname><given-names>MD</given-names></name><name><surname>Kotermanski</surname><given-names>SE</given-names></name><name><surname>Jackson</surname><given-names>EK</given-names></name><name><surname>Clark</surname><given-names>RSB</given-names></name><name><surname>Kochanek</surname><given-names>PM</given-names></name></person-group><article-title>Cold stress protein RBM3 responds to temperature change in an ultra-sensitive manner in young neurons</article-title><source>Neuroscience</source><year>2015</year><volume>305</volume><fpage>268</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.08.012</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>N</given-names></name><name><surname>Bachorik</surname><given-names>JL</given-names></name><name><surname>Dreyfuss</surname><given-names>G</given-names></name></person-group><article-title>Transportin-SR, a nuclear import receptor for SR proteins</article-title><source>J Cell Biol</source><year>1999</year><volume>145</volume><fpage>1145</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1083/jcb.145.6.1145</pub-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kharel</surname><given-names>P</given-names></name><name><surname>Becker</surname><given-names>G</given-names></name><name><surname>Tsvetkov</surname><given-names>V</given-names></name><name><surname>Ivanov</surname><given-names>P</given-names></name></person-group><article-title>Properties and biological impact of RNA G-quadruplexes: from order to turmoil and back</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><fpage>12534</fpage><lpage>12555</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1126</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>GH</given-names></name><name><surname>Kwon</surname><given-names>I</given-names></name></person-group><article-title>Distinct roles of hnRNPH1 low-complexity domains in splicing and transcription</article-title><source>Proc Natl Acad Sci U S A</source><year>2021</year><volume>118</volume><pub-id pub-id-type="doi">10.1073/pnas.2109668118</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>JW</given-names></name><name><surname>Mazei-Robison</surname><given-names>MS</given-names></name><name><surname>Chaudhury</surname><given-names>D</given-names></name><name><surname>Juarez</surname><given-names>B</given-names></name><name><surname>LaPlant</surname><given-names>Q</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Scobie</surname><given-names>KN</given-names></name><name><surname>Damez-Werno</surname><given-names>D</given-names></name><etal/></person-group><article-title>BDNF is a negative modulator of morphine action</article-title><source>Science</source><year>2012</year><volume>338</volume><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1126/science.1222265</pub-id></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langer</surname><given-names>LM</given-names></name><name><surname>Bonneau</surname><given-names>F</given-names></name><name><surname>Gat</surname><given-names>Y</given-names></name><name><surname>Conti</surname><given-names>E</given-names></name></person-group><article-title>Cryo-EM reconstructions of inhibitor-bound SMG1 kinase reveal an autoinhibitory state dependent on SMG8</article-title><source>Elife</source><year>2021</year><volume>10</volume><pub-id pub-id-type="doi">10.7554/eLife.72353</pub-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lareau</surname><given-names>LF</given-names></name><name><surname>Inada</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>RE</given-names></name><name><surname>Wengrod</surname><given-names>JC</given-names></name><name><surname>Brenner</surname><given-names>SE</given-names></name></person-group><article-title>Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements</article-title><source>Nature</source><year>2007</year><volume>446</volume><fpage>926</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1038/nature05676</pub-id></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laustriat</surname><given-names>D</given-names></name><name><surname>Gide</surname><given-names>J</given-names></name><name><surname>Barrault</surname><given-names>L</given-names></name><name><surname>Chautard</surname><given-names>E</given-names></name><name><surname>Benoit</surname><given-names>C</given-names></name><name><surname>Auboeuf</surname><given-names>D</given-names></name><name><surname>Boland</surname><given-names>A</given-names></name><name><surname>Battail</surname><given-names>C</given-names></name><name><surname>Artiguenave</surname><given-names>F</given-names></name><name><surname>Deleuze</surname><given-names>J-F</given-names></name><etal/></person-group><article-title>In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin</article-title><source>Mol Ther Nucleic Acids</source><year>2015</year><volume>4</volume><elocation-id>e262</elocation-id><pub-id pub-id-type="doi">10.1038/mtna.2015.35</pub-id></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefevre</surname><given-names>EM</given-names></name><name><surname>Pisansky</surname><given-names>MT</given-names></name><name><surname>Toddes</surname><given-names>C</given-names></name><name><surname>Baruffaldi</surname><given-names>F</given-names></name><name><surname>Pravetoni</surname><given-names>M</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Kono</surname><given-names>TJY</given-names></name><name><surname>Rothwell</surname><given-names>PE</given-names></name></person-group><article-title>Interruption of continuous opioid exposure exacerbates drug-evoked adaptations in the mesolimbic dopamine system</article-title><source>Neuropsychopharmacology</source><year>2020</year><volume>45</volume><fpage>1781</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.1038/s41386-020-0643-x</pub-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llorian</surname><given-names>M</given-names></name><name><surname>Gooding</surname><given-names>C</given-names></name><name><surname>Bellora</surname><given-names>N</given-names></name><name><surname>Hallegger</surname><given-names>M</given-names></name><name><surname>Buckroyd</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Rajgor</surname><given-names>D</given-names></name><name><surname>Kayikci</surname><given-names>M</given-names></name><name><surname>Feltham</surname><given-names>J</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name><etal/></person-group><article-title>The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators</article-title><source>Nucleic Acids Res</source><year>2016</year><volume>44</volume><fpage>8933</fpage><lpage>8950</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw560</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Hitz</surname><given-names>BC</given-names></name><name><surname>Gabdank</surname><given-names>I</given-names></name><name><surname>Hilton</surname><given-names>JA</given-names></name><name><surname>Kagda</surname><given-names>MS</given-names></name><name><surname>Lam</surname><given-names>B</given-names></name><name><surname>Myers</surname><given-names>Z</given-names></name><name><surname>Sud</surname><given-names>P</given-names></name><name><surname>Jou</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>K</given-names></name><etal/></person-group><article-title>New developments on the Encyclopedia of DNA Elements (ENCODE) data portal</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><fpage>D882</fpage><lpage>D889</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1062</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molliex</surname><given-names>A</given-names></name><name><surname>Temirov</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Coughlin</surname><given-names>M</given-names></name><name><surname>Kanagaraj</surname><given-names>AP</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Mittag</surname><given-names>T</given-names></name><name><surname>Taylor</surname><given-names>JP</given-names></name></person-group><article-title>Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.09.015</pub-id></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>DY</given-names></name><name><surname>Jung</surname><given-names>M-J</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><article-title>Effects of deficient of the Hoogsteen base-pairs on the G-quadruplex stabilization and binding mode of a cationic porphyrin</article-title><source>Biochem Biophys Rep</source><year>2015</year><volume>2</volume><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.bbrep.2015.03.012</pub-id></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller-McNicoll</surname><given-names>M</given-names></name><name><surname>Rossbach</surname><given-names>O</given-names></name><name><surname>Hui</surname><given-names>J</given-names></name><name><surname>Medenbach</surname><given-names>J</given-names></name></person-group><article-title>Auto-regulatory feedback by RNA-binding proteins</article-title><source>J Mol Cell Biol</source><year>2019</year><volume>11</volume><fpage>930</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1093/jmcb/mjz043</pub-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natua</surname><given-names>S</given-names></name><name><surname>Ashok</surname><given-names>C</given-names></name><name><surname>Shukla</surname><given-names>S</given-names></name></person-group><article-title>Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige</article-title><source>Cell Mol Life Sci</source><year>2021</year><volume>78</volume><fpage>2729</fpage><lpage>2747</lpage><pub-id pub-id-type="doi">10.1007/s00018-020-03727-0</pub-id></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>A</given-names></name><name><surname>Meinke</surname><given-names>S</given-names></name><name><surname>Goldammer</surname><given-names>G</given-names></name><name><surname>Strauch</surname><given-names>M</given-names></name><name><surname>Schubert</surname><given-names>D</given-names></name><name><surname>Timmermann</surname><given-names>B</given-names></name><name><surname>Heyd</surname><given-names>F</given-names></name><name><surname>Preußner</surname><given-names>M</given-names></name></person-group><article-title>Alternative splicing coupled mRNA decay shapes the temperature-dependent transcriptome</article-title><source>EMBO Rep</source><year>2020</year><volume>21</volume><elocation-id>e51369</elocation-id><pub-id pub-id-type="doi">10.15252/embr.202051369</pub-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawlowski</surname><given-names>M</given-names></name><name><surname>Ortmann</surname><given-names>D</given-names></name><name><surname>Bertero</surname><given-names>A</given-names></name><name><surname>Tavares</surname><given-names>JM</given-names></name><name><surname>Pedersen</surname><given-names>RA</given-names></name><name><surname>Vallier</surname><given-names>L</given-names></name><name><surname>Kotter</surname><given-names>MRN</given-names></name></person-group><article-title>Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes</article-title><source>Stem Cell Reports</source><year>2017</year><volume>8</volume><fpage>803</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.02.016</pub-id></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peretti</surname><given-names>D</given-names></name><name><surname>Bastide</surname><given-names>A</given-names></name><name><surname>Radford</surname><given-names>H</given-names></name><name><surname>Verity</surname><given-names>N</given-names></name><name><surname>Molloy</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>MG</given-names></name><name><surname>Moreno</surname><given-names>JA</given-names></name><name><surname>Steinert</surname><given-names>JR</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Dinsdale</surname><given-names>D</given-names></name><etal/></person-group><article-title>RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration</article-title><source>Nature</source><year>2015</year><volume>518</volume><fpage>236</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1038/nature14142</pub-id></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peretti</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>HL</given-names></name><name><surname>Verity</surname><given-names>N</given-names></name><name><surname>Humoud</surname><given-names>I</given-names></name><name><surname>de Weerd</surname><given-names>L</given-names></name><name><surname>Swinden</surname><given-names>DP</given-names></name><name><surname>Hayes</surname><given-names>J</given-names></name><name><surname>Mallucci</surname><given-names>GR</given-names></name></person-group><article-title>TrkB signaling regulates the cold-shock protein RBM3-mediated neuroprotection</article-title><source>Life Sci Alliance</source><year>2021</year><volume>4</volume><pub-id pub-id-type="doi">10.26508/lsa.202000884</pub-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomeranz Krummel</surname><given-names>DA</given-names></name><name><surname>Oubridge</surname><given-names>C</given-names></name><name><surname>Leung</surname><given-names>AKW</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name></person-group><article-title>Crystal structure of human spliceosomal U1 snRNP at 5.5 A resolution</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/nature07851</pub-id></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Presciutti</surname><given-names>A</given-names></name><name><surname>Perman</surname><given-names>SM</given-names></name></person-group><article-title>The evolution of hypothermia for neuroprotection after cardiac arrest: a history in the making</article-title><source>Ann N Y Acad Sci</source><year>2022</year><volume>1507</volume><fpage>60</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1111/nyas.14676</pub-id></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preussner</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>HL</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Hughes</surname><given-names>D</given-names></name><name><surname>Emmerichs</surname><given-names>A-K</given-names></name><name><surname>Scalzitti</surname><given-names>S</given-names></name><name><surname>Peretti</surname><given-names>DA</given-names></name><name><surname>Swinden</surname><given-names>D</given-names></name><name><surname>Neumann</surname><given-names>A</given-names></name><name><surname>Haltenhof</surname><given-names>T</given-names></name><etal/></person-group><article-title>ASO targeting temperature-controlled RBM3 poison exon splicing prevents neurodegeneration in vivo</article-title><year>2022</year></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pullara</surname><given-names>P</given-names></name><name><surname>Alshareedah</surname><given-names>I</given-names></name><name><surname>Banerjee</surname><given-names>PR</given-names></name></person-group><article-title>Temperature-dependent reentrant phase transition of RNA–polycation mixtures</article-title><source>Soft Matter</source><year>2022</year><volume>18</volume><fpage>1342</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1039/D1SM01557E</pub-id></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichert</surname><given-names>SC</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Turner</surname><given-names>S</given-names></name><name><surname>Jaarsveld</surname><given-names>RH</given-names></name><name><surname>Massink</surname><given-names>MPG</given-names></name><name><surname>Boogaard</surname><given-names>MH</given-names></name><name><surname>Toro</surname><given-names>M</given-names></name><name><surname>Rodríguez-Palmero</surname><given-names>A</given-names></name><name><surname>Fourcade</surname><given-names>S</given-names></name><name><surname>Schlüter</surname><given-names>A</given-names></name><etal/></person-group><article-title><italic>HNRNPH1</italic> -related syndromic intellectual disability: Seven additional cases suggestive of a distinct syndromic neurodevelopmental syndrome</article-title><source>Clinical Genetics</source><year>2020</year><volume>98</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1111/cge.13765</pub-id></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riback</surname><given-names>JA</given-names></name><name><surname>Katanski</surname><given-names>CD</given-names></name><name><surname>Kear-Scott</surname><given-names>JL</given-names></name><name><surname>Pilipenko</surname><given-names>EV</given-names></name><name><surname>Rojek</surname><given-names>AE</given-names></name><name><surname>Sosnick</surname><given-names>TR</given-names></name><name><surname>Drummond</surname><given-names>DA</given-names></name></person-group><article-title>Stress-Triggered Phase Separation Is an Adaptive, Evolutionarily Tuned Response</article-title><source>Cell</source><year>2017</year><volume>168</volume><fpage>1028</fpage><lpage>1040</lpage><elocation-id>e19</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.02.027</pub-id></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>L-M</given-names></name><name><surname>Leithner</surname><given-names>C</given-names></name><name><surname>Tong</surname><given-names>G</given-names></name><name><surname>Streitberger</surname><given-names>KJ</given-names></name><name><surname>Krech</surname><given-names>J</given-names></name><name><surname>Storm</surname><given-names>C</given-names></name><name><surname>Schmitt</surname><given-names>KRL</given-names></name></person-group><article-title>RBM3 and CIRP expressions in targeted temperature management treated cardiac arrest patients—A prospective single center study</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><elocation-id>e0226005</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0226005</pub-id></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rzechorzek</surname><given-names>NM</given-names></name><name><surname>Connick</surname><given-names>P</given-names></name><name><surname>Patani</surname><given-names>R</given-names></name><name><surname>Selvaraj</surname><given-names>BT</given-names></name><name><surname>Chandran</surname><given-names>S</given-names></name></person-group><article-title>Hypothermic Preconditioning of Human Cortical Neurons Requires Proteostatic Priming</article-title><source>EBioMedicine</source><year>2015</year><volume>2</volume><fpage>528</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2015.04.004</pub-id></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skordis</surname><given-names>LA</given-names></name><name><surname>Dunckley</surname><given-names>MG</given-names></name><name><surname>Yue</surname><given-names>B</given-names></name><name><surname>Eperon</surname><given-names>IC</given-names></name><name><surname>Muntoni</surname><given-names>F</given-names></name></person-group><article-title>Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>4114</fpage><lpage>4119</lpage><pub-id pub-id-type="doi">10.1073/pnas.0633863100</pub-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridharan</surname><given-names>S</given-names></name><name><surname>Hernandez-Armendariz</surname><given-names>A</given-names></name><name><surname>Kurzawa</surname><given-names>N</given-names></name><name><surname>Potel</surname><given-names>CM</given-names></name><name><surname>Memon</surname><given-names>D</given-names></name><name><surname>Beltrao</surname><given-names>P</given-names></name><name><surname>Bantscheff</surname><given-names>M</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Cuylen-Haering</surname><given-names>S</given-names></name><name><surname>Savitski</surname><given-names>MM</given-names></name></person-group><article-title>Systematic discovery of biomolecular condensate-specific protein phosphorylation</article-title><source>Nat Chem Biol</source><year>2022</year><volume>18</volume><fpage>1104</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1038/s41589-022-01062-y</pub-id></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>F</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zuo</surname><given-names>J</given-names></name><name><surname>Saffen</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay</article-title><source>Nucleic Acids Res</source><year>2017</year><volume>45</volume><fpage>8524</fpage><lpage>8540</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx508</pub-id></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauber</surname><given-names>D</given-names></name><name><surname>Tauber</surname><given-names>G</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name></person-group><article-title>Mechanisms and Regulation of RNA Condensation in RNP Granule Formation</article-title><source>Trends Biochem Sci</source><year>2020</year><volume>45</volume><fpage>764</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2020.05.002</pub-id></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uren</surname><given-names>PJ</given-names></name><name><surname>Bahrami-Samani</surname><given-names>E</given-names></name><name><surname>de Araujo</surname><given-names>PR</given-names></name><name><surname>Vogel</surname><given-names>C</given-names></name><name><surname>Qiao</surname><given-names>M</given-names></name><name><surname>Burns</surname><given-names>SC</given-names></name><name><surname>Smith</surname><given-names>AD</given-names></name><name><surname>Penalva</surname><given-names>LOF</given-names></name></person-group><article-title>High-throughput analyses of hnRNP H1 dissects its multi-functional aspect</article-title><source>RNA Biol</source><year>2016</year><volume>13</volume><fpage>400</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1080/15476286.2015.1138030</pub-id></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vo</surname><given-names>T</given-names></name><name><surname>Brownmiller</surname><given-names>T</given-names></name><name><surname>Hall</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>TL</given-names></name><name><surname>Choudhari</surname><given-names>S</given-names></name><name><surname>Grammatikakis</surname><given-names>I</given-names></name><name><surname>Ludwig</surname><given-names>KR</given-names></name><name><surname>Caplen</surname><given-names>NJ</given-names></name></person-group><article-title>HNRNPH1 destabilizes the G-quadruplex structures formed by G-rich RNA sequences that regulate the alternative splicing of an oncogenic fusion transcript</article-title><source>Nucleic Acids Res</source><year>2022</year><volume>50</volume><fpage>6474</fpage><lpage>6496</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac409</pub-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wellmann</surname><given-names>S</given-names></name><name><surname>Bührer</surname><given-names>C</given-names></name><name><surname>Moderegger</surname><given-names>E</given-names></name><name><surname>Zelmer</surname><given-names>A</given-names></name><name><surname>Kirschner</surname><given-names>R</given-names></name><name><surname>Koehne</surname><given-names>P</given-names></name><name><surname>Fujita</surname><given-names>J</given-names></name><name><surname>Seeger</surname><given-names>K</given-names></name></person-group><article-title>Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism</article-title><source>J Cell Sci</source><year>2004</year><volume>117</volume><fpage>1785</fpage><lpage>1794</lpage><pub-id pub-id-type="doi">10.1242/jcs.01026</pub-id></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wellmann</surname><given-names>S</given-names></name><name><surname>Truss</surname><given-names>M</given-names></name><name><surname>Bruder</surname><given-names>E</given-names></name><name><surname>Tornillo</surname><given-names>L</given-names></name><name><surname>Zelmer</surname><given-names>A</given-names></name><name><surname>Seeger</surname><given-names>K</given-names></name><name><surname>Bührer</surname><given-names>C</given-names></name></person-group><article-title>The RNA-binding protein RBM3 is required for cell proliferation and protects against serum deprivation-induced cell death</article-title><source>Pediatr Res</source><year>2010</year><volume>67</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1203/PDR.0b013e3181c13326</pub-id></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Goerne</surname><given-names>T</given-names></name><name><surname>Zelmer</surname><given-names>A</given-names></name><name><surname>Guzman</surname><given-names>R</given-names></name><name><surname>Kapfhammer</surname><given-names>JP</given-names></name><name><surname>Wellmann</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><article-title>The RNA-Binding Protein RBM3 Promotes Neural Stem Cell (NSC) Proliferation Under Hypoxia</article-title><source>Front Cell Dev Biol</source><year>2019</year><volume>7</volume><elocation-id>288</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2019.00288</pub-id></element-citation></ref><ref id="R61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Duncan</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Cheema</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Benjamin Miller</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Kwok</surname><given-names>CK</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>RNA G-quadruplex structure contributes to cold adaptation in plants</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>6224</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-34040-y</pub-id></element-citation></ref><ref id="R62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name></person-group><article-title>Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion</article-title><source>Methods Mol Biol</source><year>2022</year><volume>2434</volume><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-2010-6_3</pub-id></element-citation></ref><ref id="R63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Bregere</surname><given-names>C</given-names></name><name><surname>Zelmer</surname><given-names>A</given-names></name><name><surname>Goerne</surname><given-names>T</given-names></name><name><surname>Kapfhammer</surname><given-names>JP</given-names></name><name><surname>Guzman</surname><given-names>R</given-names></name><name><surname>Wellmann</surname><given-names>S</given-names></name></person-group><article-title>RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>3983</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-11870-x</pub-id></element-citation></ref><ref id="R64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimowska</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Munguba</surname><given-names>G</given-names></name><name><surname>Jackson</surname><given-names>MR</given-names></name><name><surname>Alpatov</surname><given-names>R</given-names></name><name><surname>Simmons</surname><given-names>MN</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Sugrue</surname><given-names>SP</given-names></name></person-group><article-title>Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal epithelial cells</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>4715</fpage><lpage>4723</lpage><pub-id pub-id-type="doi">10.1167/iovs.03-0240</pub-id></element-citation></ref><ref id="R65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>S</given-names></name><name><surname>Enculescu</surname><given-names>M</given-names></name><name><surname>Setty</surname><given-names>ST</given-names></name><name><surname>Cortés-López</surname><given-names>M</given-names></name><name><surname>de Almeida</surname><given-names>BP</given-names></name><name><surname>Sutandy</surname><given-names>FXR</given-names></name><name><surname>Schulz</surname><given-names>L</given-names></name><name><surname>Busch</surname><given-names>A</given-names></name><name><surname>Seiler</surname><given-names>M</given-names></name><name><surname>Ebersberger</surname><given-names>S</given-names></name><etal/></person-group><article-title>Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><elocation-id>3315</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05748-7</pub-id></element-citation></ref><ref id="R66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>AM</given-names></name><name><surname>Capitanchik</surname><given-names>C</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name><name><surname>Luscombe</surname><given-names>NM</given-names></name></person-group><article-title>clipplotr - a comparative visualisation and analysis tool for CLIP data</article-title><year>2021</year></element-citation></ref><ref id="R67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id></element-citation></ref><ref id="R68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewels</surname><given-names>PA</given-names></name><name><surname>Peltzer</surname><given-names>A</given-names></name><name><surname>Fillinger</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>H</given-names></name><name><surname>Alneberg</surname><given-names>J</given-names></name><name><surname>Wilm</surname><given-names>A</given-names></name><name><surname>Garcia</surname><given-names>MU</given-names></name><name><surname>Di Tommaso</surname><given-names>P</given-names></name><name><surname>Nahnsen</surname><given-names>S</given-names></name></person-group><article-title>The nf-core framework for community-curated bioinformatics pipelines</article-title><source>Nat Biotechnol</source><year>2020</year><volume>38</volume><fpage>276</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0439-x</pub-id></element-citation></ref><ref id="R69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikin</surname><given-names>O</given-names></name><name><surname>D’Antonio</surname><given-names>L</given-names></name><name><surname>Bagga</surname><given-names>PS</given-names></name></person-group><article-title>QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>W676</fpage><lpage>W682</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl253</pub-id></element-citation></ref><ref id="R70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>MR</given-names></name><name><surname>Boyle</surname><given-names>JA</given-names></name><name><surname>Hardin</surname><given-names>JA</given-names></name><name><surname>Steitz</surname><given-names>JA</given-names></name></person-group><article-title>Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus</article-title><source>Science</source><year>1981</year><volume>211</volume><fpage>400</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1126/science.6164096</pub-id></element-citation></ref><ref id="R71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Handsaker</surname><given-names>B</given-names></name><name><surname>Wysoker</surname><given-names>A</given-names></name><name><surname>Fennell</surname><given-names>T</given-names></name><name><surname>Ruan</surname><given-names>J</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><name><surname>Marth</surname><given-names>G</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><etal/></person-group><article-title>1000 genome project data processing subgroup. The sequence alignment/map format and SAMtools</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage></element-citation></ref><ref id="R72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Liu</surname><given-names>JS</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><article-title>MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><elocation-id>554</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0554-4</pub-id></element-citation></ref><ref id="R73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="R74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzakopian</surname><given-names>E</given-names></name><name><surname>Strong</surname><given-names>A</given-names></name><name><surname>Iyer</surname><given-names>V</given-names></name><name><surname>Hodgkins</surname><given-names>A</given-names></name><name><surname>Tzelepis</surname><given-names>K</given-names></name><name><surname>Antunes</surname><given-names>L</given-names></name><name><surname>Friedrich</surname><given-names>MJ</given-names></name><name><surname>Kang</surname><given-names>Q</given-names></name><name><surname>Davidson</surname><given-names>T</given-names></name><name><surname>Lamberth</surname><given-names>J</given-names></name><etal/></person-group><article-title>Enhancing the genome editing toolbox: genome wide CRISPR arrayed libraries</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><elocation-id>2244</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-01766-5</pub-id></element-citation></ref><ref id="R75"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>H</given-names></name><name><surname>Ewels</surname><given-names>P</given-names></name><name><surname>Peltzer</surname><given-names>A</given-names></name><name><surname>Hammarén</surname><given-names>R</given-names></name><name><surname>Botvinnik</surname><given-names>O</given-names></name><name><surname>Sturm</surname><given-names>G</given-names></name><name><surname>Moreno</surname><given-names>D</given-names></name><name><surname>Vemuri</surname><given-names>P</given-names></name><name><surname>silviamorins Pantano</surname><given-names>L</given-names></name><etal/></person-group><source>nf-core/rnaseq: nf-core/rnaseq v3.5 - Copper Chameleon</source><publisher-name>Zenodo</publisher-name><year>2021</year></element-citation></ref><ref id="R76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawlowski</surname><given-names>M</given-names></name><name><surname>Ortmann</surname><given-names>D</given-names></name><name><surname>Bertero</surname><given-names>A</given-names></name><name><surname>Tavares</surname><given-names>JM</given-names></name><name><surname>Pedersen</surname><given-names>RA</given-names></name><name><surname>Vallier</surname><given-names>L</given-names></name><name><surname>Kotter</surname><given-names>MRN</given-names></name></person-group><article-title>Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes</article-title><source>Stem Cell Reports</source><year>2021</year><volume>8</volume><fpage>803</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.02.016</pub-id></element-citation></ref><ref id="R77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><etal/></person-group><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nat Methods</source><year>2012</year><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></element-citation></ref><ref id="R78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Lu</surname><given-names>Z-X</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Henry</surname><given-names>MD</given-names></name><name><surname>Wu</surname><given-names>YN</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name></person-group><article-title>rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><fpage>E5593</fpage><lpage>E5601</lpage><pub-id pub-id-type="doi">10.1073/pnas.1419161111</pub-id></element-citation></ref><ref id="R79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Gable</surname><given-names>AL</given-names></name><name><surname>Nastou</surname><given-names>KC</given-names></name><name><surname>Lyon</surname><given-names>D</given-names></name><name><surname>Kirsch</surname><given-names>R</given-names></name><name><surname>Pyysalo</surname><given-names>S</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Legeay</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>T</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><etal/></person-group><article-title>The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>49</volume><fpage>D605</fpage><lpage>D612</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1074</pub-id></element-citation></ref><ref id="R80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Pache</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Khodabakhshi</surname><given-names>AH</given-names></name><name><surname>Tanaseichuk</surname><given-names>O</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Chanda</surname><given-names>SK</given-names></name></person-group><article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>1523</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>RBM3 CRISPR knockout screen identifies splicing factors as key RBM3 regulators. See also <xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref> and Table S2.</title><p>(A) Representative images and quantification of somal intensity of GFP-RBM3 i-neurons at 37°C or after 72h cooling at 32°C. Nuclei and cells are outlined by white and yellow dashed lines, respectively. N= 3</p><p>(B) Western blots and quantification of RBM3 and GFP normalised to GAPDH in GFP-RBM3 i-neurons at 37°C or 32°C (72h).</p><p>(C) Schematic of experimental steps in RBM3 CRISPR screen in i-neurons. GFP-RBM3 iPSCs stably expressing Cas9 after 4 days of Dox-induced differentiation are transduced with a whole-genome lentiviral sgRNA library expressing a BFP reporter. 10-12 days after transduction, the i-neuron cultures are incubated at 32°C for 72h, followed by FACS to sort BFP-positive i-neurons with the highest and lowest 25% GFP fluorescence intensity into separate pools. N = 2 GFP-RBM3 clones and 3 biological replicates.</p><p>(D-E) Top 100 RBM3 positive regulator candidates with their sgRNAs enriched in the low-GFP i-neuron pool (D). Top 100 RBM3 negative regulator candidates with their sgRNAs enriched in the high-GFP i-neuron pool (E). Genes ranked by statistical significance (FDR). Horizontal dashed line: FDR=0.05.</p><p>(F) The top-ranked Gene Ontology terms and STRING networks of 14 positive regulator candidates (FDR&lt;0.05). Genes related to RNA splicing are indicated in blue.</p><p>(G) The top-ranked Gene Ontology terms and STRING networks of 95 positive regulator candidates (FDR&lt;0.05). Genes related to RNA splicing are coloured in blue. Genes involved in deubiquitination or proteasome-mediated ubiquitin-dependent protein catabolic processes are coloured in orange.</p><p>Mean ± SEM; * (p&lt;0.5), **(p &lt; 0.01), ***(p &lt; 0.001); unpaired t-tests. Scale bars: 5 μm.</p></caption><graphic xlink:href="EMS156495-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Depleting RBM3 positive regulators function in RNA splicing reduces RBM3 protein and mRNA levels. See also <xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref> and Table S3.</title><p>(A-B) Median GFP intensity of BFP-positive GFP-RBM3 i-neurons measured by flow cytometry upon the sgRNA/Cas9-mediated KO of top 30 positive (A) or negative (B) regulator candidates. Statistical analysis is performed between the specific and non-targeting sgRNA groups for positive regulators (A) or between the specific sgRNA and reporter groups for negative regulators (B) within the 37°C or 32°C (72h) population.</p><p>(C) qRT-PCR of RBM3 mRNA level normalised to 18s rRNA in i-neurons at 37°C or 32°C (72h).</p><p>(D-E) qRT-PCR of RBM3 mRNA level normalised to 18s rRNA in GFP-RBM3 i-neurons at 37°C (D) or 32°C for 72h (E) transduced with lentivirus containing specific, non-targeting sgRNA or the reporter. Statistical analysis is performed between the specific and non-targeting sgRNA for negative regulators in (D) and positive regulators in (E), or between the specific and reporter groups for positive regulators in (D) and negative regulators in (E). Transduction efficiencies are indicated in corresponding bars.</p><p>N≥3. Mean ± SEM; n.s. (not significant), * (p&lt;0.5), **(p &lt; 0.01), ***(p &lt; 0.001);</p><p>One-way ANOVA with multiple comparisons in (A), (B), (D), (E), unpaired t-tests in (C).</p></caption><graphic xlink:href="EMS156495-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Hypothermia represses RBM3 mRNA poison exon inclusion. See also <xref ref-type="supplementary-material" rid="SD1">Fig. S3</xref>.</title><p>(A) Sashimi plots of RBM3 transcripts in WT i-neurons at 37°C and 32°C (72h), showing major alternatively spliced isoforms. Differentially spliced Exon 3a-L and 3a-S junctions between 37°C and 32°C conditions are shown in red. N= 4.</p><p>(B) PSI values of RBM3 Exon 3a-L and 3a-S relative to Exon 3 and 4 in i-neurons at 37°C or 32°C (72h).</p><p>(C) Schematics of RBM3 Exon 3a, or poison exon (PE), alternative splicing and the resulting PE-included (left) or PE-skipped (right) mRNA products. RT-PCR primer pair amplifying Exon 2-4 are indicated by blue arrows.</p><p>(D) RT-PCR of RBM3 mRNA (Exon 2-4) in i-neurons at 37°C or 32°C (72h) in the presence or absence of SMG1 inhibitor. PSI values of RBM3 PE are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms.</p><p>(E) qRT-PCR using a combination of primers targeting Exon 3a, Exon 3 or Exon 4-5 quantifies the PSI values of RBM3 PE (Exon 3a, including both 3a-L and 3a-S) relative to Exon 3 or Exon 4-5 at 37°C or 32°C (72h) in the presence or absence of SMG1 inhibitor.</p><p>(F) RT-PCR of RBM3 mRNA (Exon 2-4) in HeLa cells at 37°C and 32°C (48h) in the presence or absence of SMG1 inhibitor. PSI values of RBM3 PE are depicted in the graph on the right.</p><p>(G) Schematics and RT-PCR of RBM3 minigene (Exon 1-4), flanked by unique sequences (thick black bars) to distinguish it from endogenous transcripts during PCR amplification, expressed in HeLa cells at 37°C or 32°C (48h), in the presence or absence of SMG1 inhibitor. PSI values of RBM3 PE are depicted in the graph on the right.</p><p>N≥3. Mean ± SEM; * (p&lt;0.5), **(p &lt; 0.01), ***(p &lt; 0.001); FDR calculated by rMATS program in (B); unpaired t-tests in (E); paired t-test in (D), (F), (G).</p></caption><graphic xlink:href="EMS156495-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>HNRNPH1 promotes RBM3 mRNA poison exon skipping. See also <xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>.</title><p>(A-B) qRT-PCR quantifying the PSI values of RBM3 PE relative to RBM3 mRNA in WT i-neurons at 37°C (A) or 32°C (72h) (B), when NMD is blocked by SMG1 inhibitor. Statistical analysis is performed between the specific and non-targeting sgRNA groups.</p><p>(C) PSI values of RBM3 Exon 3a-L in control and HNRNPH1-knocked down K562 and HepG2 cells. RNA-Seq data from ENCODE Project, 2 isogenic replicates are included.</p><p>(D-E) RT-PCR of endogenous RBM3 (D) and expressed RBM3 minigene (E) in control (scramble siRNA) or HNRNPH1-knocked down HeLa cells at 37°C or 32°C (48h), in the presence or absence of SMG1 inhibitor. The ratio of PSI values between HNRNPH1 KD and control shown for only the SMG1 i-treated conditions.</p><p>(F-G) RT-PCR of endogenous RBM3 (F) and expressed RBM3 minigene (G) in SMG1 inhibitor-treated control (untransfected) or FLAG-HNRNPH1-overexpressed (OE) HEK293T cells at 37°C. PSI values of RBM3 PE are shown in the graphs on the right respectively.</p><p>(H) Analysis of public HNRNPH1 iCLIP dataset in two replicates, mapped to RBM3 Exon 3-4. Crosslink counts are normalised to library size. RNA G quadruplexes (rG4) are predicted using QGRS mapper. The position of the GGGG motif deleted in the mutant RBM3 minigene is shown in pink.</p><p>(I) RT-PCR of WT and delGGGG RBM3 minigenes in HeLa cells at 37°C or 32°C (48h) treated with SMG1 inhibitor. PSI values of RBM3 PE are depicted in the adjacent graph</p><p>N≥3 Mean ± SEM; * (p&lt;0.5), **(p &lt; 0.01), ***(p &lt; 0.001); one-way ANOVA with multiple comparisons in (A), (B); FDR calculated by rMATS program in (C), paired t-tests in (D)-(G), (I).</p></caption><graphic xlink:href="EMS156495-f004"/></fig></floats-group></article>